{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 79790, "items": [{"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T17:18:09Z", "timestamp": 1575307089118}, "reference-count": 188, "publisher": "Springer Science and Business Media LLC", "issue": "41", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2008, 9, 1]], "date-time": "2008-09-01T00:00:00Z", "timestamp": 1220227200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2008, 9]]}, "DOI": "10.1038/onc.2008.247", "type": "journal-article", "created": {"date-parts": [[2008, 9, 16]], "date-time": "2008-09-16T07:04:59Z", "timestamp": 1221548699000}, "page": "5527-5541", "source": "Crossref", "is-referenced-by-count": 428, "title": ["The PTEN\u2013PI3K pathway: of feedbacks and cross-talks"], "prefix": "10.1038", "volume": "27", "author": [{"given": "A", "family": "Carracedo", "sequence": "first", "affiliation": []}, {"given": "P P", "family": "Pandolfi", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 9, 15]]}, "reference": [{"key": "BFonc2008247_CR1", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1042/BJ20071403", "volume": "412", "author": "Y Ahn", "year": "2008", "unstructured": "Ahn Y, Hwang CY, Lee SR, Kwon KS, Lee C . (2008). Tumor suppressor PTEN mediates a negative regulation of E3 ubiquitin-protein ligase Nedd4. Biochem J 412: 331\u2013338.", "journal-title": "Biochem J"}, {"key": "BFonc2008247_CR2", "doi-asserted-by": "crossref", "first-page": "1549", "DOI": "10.1093/hmg/11.13.1549", "volume": "11", "author": "C Albuquerque", "year": "2002", "unstructured": "Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJ et al. (2002). The \u2018just-right\u2019 signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 11: 1549\u20131560.", "journal-title": "Hum Mol Genet"}, {"key": "BFonc2008247_CR3", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1016/S0960-9822(06)00122-9", "volume": "7", "author": "DR Alessi", "year": "1997", "unstructured": "Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB et al. (1997). Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7: 261\u2013269.", "journal-title": "Curr Biol"}, {"key": "BFonc2008247_CR4", "doi-asserted-by": "crossref", "first-page": "2569", "DOI": "10.1172/JCI118705", "volume": "97", "author": "K Almind", "year": "1996", "unstructured": "Almind K, Inoue G, Pedersen O, Kahn CR . (1996). A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 97: 2569\u20132575.", "journal-title": "J Clin Invest"}, {"key": "BFonc2008247_CR5", "doi-asserted-by": "crossref", "first-page": "1955", "DOI": "10.1038/sj.onc.1205276", "volume": "21", "author": "M Ashcroft", "year": "2002", "unstructured": "Ashcroft M, Ludwig RL, Woods DB, Copeland TD, Weber HO, MacRae EJ et al. (2002). Phosphorylation of HDM2 by Akt. Oncogene 21: 1955\u20131962.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR6", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1042/BJ20071427", "volume": "410", "author": "JM Backer", "year": "2008", "unstructured": "Backer JM . (2008). The regulation and function of class III PI3Ks: novel roles for Vps34. Biochem J 410: 1\u201317.", "journal-title": "Biochem J"}, {"key": "BFonc2008247_CR7", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1038/nrc1753", "volume": "5", "author": "AG Bader", "year": "2005", "unstructured": "Bader AG, Kang S, Zhao L, Vogt PK . (2005). Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5: 921\u2013929.", "journal-title": "Nat Rev Cancer"}, {"key": "BFonc2008247_CR8", "doi-asserted-by": "crossref", "first-page": "977", "DOI": "10.1126/science.1147379", "volume": "318", "author": "X Bai", "year": "2007", "unstructured": "Bai X, Ma D, Liu A, Shen X, Wang QJ, Liu Y et al. (2007). Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science 318: 977\u2013980.", "journal-title": "Science"}, {"key": "BFonc2008247_CR9", "doi-asserted-by": "crossref", "first-page": "2351", "DOI": "10.2337/diabetes.54.8.2351", "volume": "54", "author": "GK Bandyopadhyay", "year": "2005", "unstructured": "Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM . (2005). Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54: 2351\u20132359.", "journal-title": "Diabetes"}, {"key": "BFonc2008247_CR10", "doi-asserted-by": "crossref", "first-page": "pe49", "DOI": "10.1126/stke.3622006pe49", "volume": "2006", "author": "DF Barber", "year": "2006", "unstructured": "Barber DF, Alvarado-Kristensson M, Gonzalez-Garcia A, Pulido R, Carrera AC . (2006). PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase. Sci STKE 2006: pe49.", "journal-title": "Sci STKE"}, {"key": "BFonc2008247_CR11", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1080/13547500701676019", "volume": "13", "author": "J Baselga", "year": "2008", "unstructured": "Baselga J, Rothenberg ML, Tabernero J, Seoane J, Daly T, Cleverly A et al. (2008). TGF-beta signalling-related markers in cancer patients with bone metastasis. Biomarkers 13: 217\u2013236.", "journal-title": "Biomarkers"}, {"key": "BFonc2008247_CR12", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1016/j.molcel.2005.03.020", "volume": "18", "author": "JR Bayascas", "year": "2005", "unstructured": "Bayascas JR, Alessi DR . (2005). Regulation of Akt/PKB Ser473 phosphorylation. Mol Cell 18: 143\u2013145.", "journal-title": "Mol Cell"}, {"key": "BFonc2008247_CR13", "first-page": "1313", "volume": "6", "author": "SE Beck", "year": "2007", "unstructured": "Beck SE, Carethers JM . (2007). BMP suppresses PTEN expression via RAS/ERK signaling. Cancer Biol Ther 6: 1313\u20131317.", "journal-title": "Cancer Biol Ther"}, {"key": "BFonc2008247_CR14", "doi-asserted-by": "crossref", "first-page": "1021", "DOI": "10.1016/S0006-291X(02)00333-9", "volume": "293", "author": "CE Berg", "year": "2002", "unstructured": "Berg CE, Lavan BE, Rondinone CM . (2002). Rapamycin partially prevents insulin resistance induced by chronic insulin treatment. Biochem Biophys Res Commun 293: 1021\u20131027.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "BFonc2008247_CR15", "doi-asserted-by": "crossref", "first-page": "779", "DOI": "10.1038/nature05029", "volume": "442", "author": "R Bernardi", "year": "2006", "unstructured": "Bernardi R, Guernah I, Jin D, Grisendi S, Alimonti A, Teruya-Feldstein J et al. (2006). PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature 442: 779\u2013785.", "journal-title": "Nature"}, {"key": "BFonc2008247_CR16", "doi-asserted-by": "crossref", "first-page": "7421", "DOI": "10.1073/pnas.96.13.7421", "volume": "96", "author": "WH Biggs III", "year": "1999", "unstructured": "Biggs III WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC . (1999). Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 96: 7421\u20137426.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR17", "doi-asserted-by": "crossref", "first-page": "857", "DOI": "10.1016/S0092-8674(00)80595-4", "volume": "96", "author": "A Brunet", "year": "1999", "unstructured": "Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857\u2013868.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR18", "doi-asserted-by": "crossref", "first-page": "2258", "DOI": "10.1038/onc.2008.29", "volume": "27", "author": "BM Burgering", "year": "2008", "unstructured": "Burgering BM . (2008). A brief introduction to FOXOlogy. Oncogene 27: 2258\u20132262.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR19", "doi-asserted-by": "crossref", "first-page": "1655", "DOI": "10.1126/science.296.5573.1655", "volume": "296", "author": "LC Cantley", "year": "2002", "unstructured": "Cantley LC . (2002). The phosphoinositide 3-kinase pathway. Science 296: 1655\u20131657.", "journal-title": "Science"}, {"key": "BFonc2008247_CR20", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1038/nature05933", "volume": "448", "author": "JD Carpten", "year": "2007", "unstructured": "Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM et al. (2007). A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448: 439\u2013444.", "journal-title": "Nature"}, {"key": "BFonc2008247_CR21", "unstructured": "Carracedo A, Ma L, Teruya-Feldstein L, Rojo F, Salmena L, Alimonti A et al. (2008). Inhibition of mTORC1 leads to MAPK pathway activation through a P13K-dependent feedback loop in human cancer. J Clin Invest (in press).", "DOI": "10.1172/JCI34739", "doi-asserted-by": "crossref"}, {"key": "BFonc2008247_CR22", "doi-asserted-by": "crossref", "first-page": "550el", "DOI": "10.1016/j.cell.2008.04.023", "volume": "133", "author": "A Carracedo", "year": "2008", "unstructured": "Carracedo A, Salmena L, Pandolfi PP . (2008). SnapShot: PTEN signaling pathways. Cell 133: 550el.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR23", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1016/S0092-8674(00)81294-5", "volume": "84", "author": "H Chen", "year": "1996", "unstructured": "Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ et al. (1996). Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491\u2013495.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR24", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1038/nature03918", "volume": "436", "author": "Z Chen", "year": "2005", "unstructured": "Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. (2005). Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725\u2013730.", "journal-title": "Nature"}, {"key": "BFonc2008247_CR25", "doi-asserted-by": "crossref", "first-page": "e8", "DOI": "10.1371/journal.pmed.0050008", "volume": "5", "author": "TF Cloughesy", "year": "2008", "unstructured": "Cloughesy TF, Yoshimoto K, Nghiemphu P, Brown K, Dang J, Zhu S et al. (2008). Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med 5: e8.", "journal-title": "PLoS Med"}, {"key": "BFonc2008247_CR26", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1038/378785a0", "volume": "378", "author": "DA Cross", "year": "1995", "unstructured": "Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA . (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785\u2013789.", "journal-title": "Nature"}, {"key": "BFonc2008247_CR27", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1083/jcb.200707018", "volume": "181", "author": "B Culjkovic", "year": "2008", "unstructured": "Culjkovic B, Tan K, Orolicki S, Amri A, Meloche S, Borden KL . (2008). The eIF4E RNA regulon promotes the Akt signaling pathway. J Cell Biol 181: 51\u201363.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008247_CR28", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1210/jc.2002-020807", "volume": "88", "author": "R D'Alfonso", "year": "2003", "unstructured": "D'Alfonso R, Marini MA, Frittitta L, Sorge R, Frontoni S, Porzio O et al. (2003). Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes. J Clin Endocrinol Metab 88: 317\u2013322.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "BFonc2008247_CR29", "doi-asserted-by": "crossref", "first-page": "35364", "DOI": "10.1074/jbc.M205838200", "volume": "277", "author": "HC Dan", "year": "2002", "unstructured": "Dan HC, Sun M, Yang L, Feldman RI, Sui XM, Ou CC et al. (2002). Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem 277: 35364\u201335370.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR30", "doi-asserted-by": "crossref", "first-page": "687", "DOI": "10.1126/science.278.5338.687", "volume": "278", "author": "L del Peso", "year": "1997", "unstructured": "del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687\u2013689.", "journal-title": "Science"}, {"key": "BFonc2008247_CR31", "doi-asserted-by": "crossref", "first-page": "2561", "DOI": "10.1038/sj.onc.1210918", "volume": "27", "author": "A Denley", "year": "2008", "unstructured": "Denley A, Kang S, Karst U, Vogt PK . (2008). Oncogenic signaling of class I PI3K isoforms. Oncogene 27: 2561\u20132574.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR32", "doi-asserted-by": "crossref", "first-page": "3930", "DOI": "10.1038/sj.onc.1210175", "volume": "26", "author": "G Denning", "year": "2007", "unstructured": "Denning G, Jean-Joseph B, Prince C, Durden DL, Vogt PK . (2007). A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth. Oncogene 26: 3930\u20133940.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR33", "doi-asserted-by": "crossref", "first-page": "2122", "DOI": "10.1126/science.285.5436.2122", "volume": "285", "author": "A Di Cristofano", "year": "1999", "unstructured": "Di Cristofano A, Kotsi P, Peng YF, Cordon-Cardo C, Elkon KB, Pandolfi PP . (1999). Impaired Fas response and autoimmunity in Pten+/\u2212 mice. Science 285: 2122\u20132125.", "journal-title": "Science"}, {"key": "BFonc2008247_CR34", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1038/1235", "volume": "19", "author": "A Di Cristofano", "year": "1998", "unstructured": "Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP . (1998). Pten is essential for embryonic development and tumour suppression. Nat Genet 19: 348\u2013355.", "journal-title": "Nat Genet"}, {"key": "BFonc2008247_CR35", "doi-asserted-by": "publisher", "first-page": "467", "DOI": "10.1126/science.1130276", "volume": "314", "author": "NV Dorrello", "year": "2006", "unstructured": "Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M . (2006). S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314: 467\u2013471.", "journal-title": "Science"}, {"key": "BFonc2008247_CR36", "doi-asserted-by": "crossref", "first-page": "1574", "DOI": "10.1126/science.1079817", "volume": "300", "author": "K Du", "year": "2003", "unstructured": "Du K, Herzig S, Kulkarni RN, Montminy M . (2003). TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300: 1574\u20131577.", "journal-title": "Science"}, {"issue": "41", "key": "BFonc2008247_CR37", "doi-asserted-by": "crossref", "first-page": "5416", "DOI": "10.1038/onc.2008.239", "volume": "27", "author": "R Endersby", "year": "2008", "unstructured": "Endersby R, Baker SJ . (2008). PTEN Signaling in Brain: Neuropathology and Tumorigenesis. Oncogene (in press).", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR38", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1002/humu.10257", "volume": "22", "author": "C Eng", "year": "2003", "unstructured": "Eng C . (2003). PTEN: one gene, many syndromes. Hum Mutat 22: 183\u2013198.", "journal-title": "Hum Mutat"}, {"key": "BFonc2008247_CR39", "doi-asserted-by": "crossref", "first-page": "606", "DOI": "10.1038/nrg1879", "volume": "7", "author": "JA Engelman", "year": "2006", "unstructured": "Engelman JA, Luo J, Cantley LC . (2006). The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606\u2013619.", "journal-title": "Nat Rev Genet"}, {"key": "BFonc2008247_CR40", "doi-asserted-by": "crossref", "first-page": "1468", "DOI": "10.1210/jc.2002-020933", "volume": "88", "author": "DL Esposito", "year": "2003", "unstructured": "Esposito DL, Li Y, Vanni C, Mammarella S, Veschi S, Della Loggia F et al. (2003). A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling. J Clin Endocrinol Metab 88: 1468\u20131475.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "BFonc2008247_CR41", "doi-asserted-by": "crossref", "first-page": "671", "DOI": "10.1038/nrd2062", "volume": "5", "author": "S Faivre", "year": "2006", "unstructured": "Faivre S, Kroemer G, Raymond E . (2006). Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 5: 671\u2013688.", "journal-title": "Nat Rev Drug Discov"}, {"key": "BFonc2008247_CR42", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1016/j.cub.2007.11.051", "volume": "18", "author": "M Fivaz", "year": "2008", "unstructured": "Fivaz M, Bandara S, Inoue T, Meyer T . (2008). Robust neuronal symmetry breaking by Ras-triggered local positive feedback. Curr Biol 18: 44\u201350.", "journal-title": "Curr Biol"}, {"key": "BFonc2008247_CR43", "doi-asserted-by": "crossref", "first-page": "476", "DOI": "10.1016/j.neuroscience.2007.10.048", "volume": "151", "author": "MM Fraser", "year": "2008", "unstructured": "Fraser MM, Bayazitov IT, Zakharenko SS, Baker SJ . (2008). Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Neuroscience 151: 476\u2013488.", "journal-title": "Neuroscience"}, {"key": "BFonc2008247_CR44", "doi-asserted-by": "crossref", "first-page": "7773", "DOI": "10.1158/0008-5472.CAN-04-2487", "volume": "64", "author": "MM Fraser", "year": "2004", "unstructured": "Fraser MM, Zhu X, Kwon CH, Uhlmann EJ, Gutmann DH, Baker SJ . (2004). Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res 64: 7773\u20137779.", "journal-title": "Cancer Res"}, {"key": "BFonc2008247_CR45", "doi-asserted-by": "crossref", "first-page": "28706", "DOI": "10.1074/jbc.M203668200", "volume": "277", "author": "N Fujita", "year": "2002", "unstructured": "Fujita N, Sato S, Katayama K, Tsuruo T . (2002). Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem 277: 28706\u201328713.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR46", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1016/S0092-8674(02)00755-9", "volume": "109", "author": "S Funamoto", "year": "2002", "unstructured": "Funamoto S, Meili R, Lee S, Parry L, Firtel RA . (2002). Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 109: 611\u2013623.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR47", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/j.molcel.2005.03.008", "volume": "18", "author": "T Gao", "year": "2005", "unstructured": "Gao T, Furnari F, Newton AC . (2005). PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18: 13\u201324.", "journal-title": "Mol Cell"}, {"key": "BFonc2008247_CR48", "doi-asserted-by": "crossref", "first-page": "1457", "DOI": "10.1016/S1097-2765(03)00220-X", "volume": "11", "author": "A Garami", "year": "2003", "unstructured": "Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H et al. (2003). Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11: 1457\u20131466.", "journal-title": "Mol Cell"}, {"key": "BFonc2008247_CR49", "unstructured": "Garcia-Echeverria C, Sellers W . (2008). Drug discovery approaches to target the P13K/Akt pathway in cancer cells. Oncogene (in press).", "DOI": "10.1038/onc.2008.246", "doi-asserted-by": "crossref"}, {"key": "BFonc2008247_CR50", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1158/0008-5472.CAN-07-0669", "volume": "68", "author": "JR Garlich", "year": "2008", "unstructured": "Garlich JR, De P, Dey N, Su JD, Peng X, Miller A et al. (2008). A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity. Cancer Res 68: 206\u2013215.", "journal-title": "Cancer Res"}, {"key": "BFonc2008247_CR51", "doi-asserted-by": "crossref", "first-page": "1325", "DOI": "10.1126/science.1096706", "volume": "304", "author": "S George", "year": "2004", "unstructured": "George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC et al. (2004). A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304: 1325\u20131328.", "journal-title": "Science"}, {"key": "BFonc2008247_CR52", "doi-asserted-by": "crossref", "first-page": "6231", "DOI": "10.1073/pnas.93.13.6231", "volume": "93", "author": "N Ghilardi", "year": "1996", "unstructured": "Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC . (1996). Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 93: 6231\u20136235.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR53", "doi-asserted-by": "crossref", "first-page": "8199", "DOI": "10.1074/jbc.M209153200", "volume": "278", "author": "MW Greene", "year": "2003", "unstructured": "Greene MW, Sakaue H, Wang L, Alessi DR, Roth RA . (2003). Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by serine 312 phosphorylation. J Biol Chem 278: 8199\u20138211.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR54", "doi-asserted-by": "crossref", "first-page": "1375", "DOI": "10.1083/jcb.143.5.1375", "volume": "143", "author": "J Gu", "year": "1998", "unstructured": "Gu J, Tamura M, Yamada KM . (1998). Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 143: 1375\u20131383.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008247_CR55", "first-page": "27354", "volume": "275", "author": "KL Guan", "year": "2000", "unstructured": "Guan KL, Figueroa C, Brtva TR, Zhu T, Taylor J, Barber TD et al. (2000). Negative regulation of the serine/threonine kinase B-Raf by Akt. J Biol Chem 275: 27354\u201327359.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR56", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/j.ccr.2007.05.008", "volume": "12", "author": "DA Guertin", "year": "2007", "unstructured": "Guertin DA, Sabatini DM . (2007). Defining the role of mTOR in cancer. Cancer Cell 12: 9\u201322.", "journal-title": "Cancer Cell"}, {"key": "BFonc2008247_CR57", "doi-asserted-by": "crossref", "first-page": "456", "DOI": "10.1016/j.cmet.2008.03.002", "volume": "7", "author": "P Gulati", "year": "2008", "unstructured": "Gulati P, Gaspers LD, Dann SG, Joaquin M, Nobukuni T, Natt F et al. (2008). Amino acids activate mTOR complex 1 via Ca(2+)/CaM signaling to hVps34. Cell Metab 7: 456\u2013465.", "journal-title": "Cell Metab"}, {"key": "BFonc2008247_CR58", "doi-asserted-by": "crossref", "first-page": "17184", "DOI": "10.1074/jbc.274.24.17184", "volume": "274", "author": "S Guo", "year": "1999", "unstructured": "Guo S, Rena G, Cichy S, He X, Cohen P, Unterman T . (1999). Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem 274: 17184\u201317192.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR59", "doi-asserted-by": "crossref", "first-page": "957", "DOI": "10.1016/j.cell.2007.03.051", "volume": "129", "author": "S Gupta", "year": "2007", "unstructured": "Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B et al. (2007). Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell 129: 957\u2013968.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR60", "doi-asserted-by": "crossref", "first-page": "L1238", "DOI": "10.1152/ajplung.00017.2008", "volume": "294", "author": "S Han", "year": "2008", "unstructured": "Han S, Ritzenthaler JD, Zheng Y, Roman J . (2008). PPAR{beta}/{delta}agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3-K and NF-{kappa}B signals. Am J Physiol Lung Cell Mol Physio 294: L1238\u2013L1249.", "journal-title": "Am J Physiol Lung Cell Mol Physio"}, {"key": "BFonc2008247_CR61", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1083/jcb.200403069", "volume": "166", "author": "LS Harrington", "year": "2004", "unstructured": "Harrington LS, Findlay GM, Gray A, Tolkacheva T, Wigfield S, Rebholz H et al. (2004). The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166: 213\u2013223.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008247_CR62", "doi-asserted-by": "crossref", "first-page": "304", "DOI": "10.1002/jcb.10135", "volume": "85", "author": "D Hartley", "year": "2002", "unstructured": "Hartley D, Cooper GM . (2002). Role of mTOR in the degradation of IRS-1: regulation of PP2A activity. J Cell Biochem 85: 304\u2013314.", "journal-title": "J Cell Biochem"}, {"key": "BFonc2008247_CR63", "doi-asserted-by": "crossref", "first-page": "783", "DOI": "10.1210/mend.14.6.0446", "volume": "14", "author": "T Haruta", "year": "2000", "unstructured": "Haruta T, Uno T, Kawahara J, Takano A, Egawa K, Sharma PM et al. (2000). A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol 14: 783\u2013794.", "journal-title": "Mol Endocrinol"}, {"key": "BFonc2008247_CR64", "doi-asserted-by": "crossref", "first-page": "639", "DOI": "10.2217/14796694.3.6.639", "volume": "3", "author": "RD Harvey", "year": "2007", "unstructured": "Harvey RD, Lonial S . (2007). PI3 kinase/AKT pathway as a therapeutic target in multiple myeloma. Future Oncol 3: 639\u2013647.", "journal-title": "Future Oncol"}, {"key": "BFonc2008247_CR65", "doi-asserted-by": "crossref", "first-page": "6742", "DOI": "10.1128/MCB.10.12.6742", "volume": "10", "author": "PK Herman", "year": "1990", "unstructured": "Herman PK, Emr SD . (1990). Characterization of VPS34, a gene required for vacuolar protein sorting and vacuole segregation in Saccharomyces cerevisiae. Mol Cell Biol 10: 6742\u20136754.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008247_CR66", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1038/sj.cdd.4401946", "volume": "14", "author": "K Hettinger", "year": "2007", "unstructured": "Hettinger K, Vikhanskaya F, Poh MK, Lee MK, de Belle I, Zhang JT et al. (2007). c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ 14: 218\u2013229.", "journal-title": "Cell Death Differ"}, {"key": "BFonc2008247_CR67", "doi-asserted-by": "crossref", "first-page": "4104", "DOI": "10.1128/MCB.00289-08", "volume": "12", "author": "J Huang", "year": "2008", "unstructured": "Huang J, Dibble CC, Matsuzaki M, Manning BD . (2008). The TSC1\u2013TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol 12: 4104\u20134115.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008247_CR68", "doi-asserted-by": "crossref", "first-page": "6356", "DOI": "10.1038/sj.onc.1205792", "volume": "21", "author": "E Im", "year": "2002", "unstructured": "Im E, von Lintig FC, Chen J, Zhuang S, Qui W, Chowdhury S et al. (2002). Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells. Oncogene 21: 6356\u20136365.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR69", "doi-asserted-by": "crossref", "first-page": "1829", "DOI": "10.1101/gad.1110003", "volume": "17", "author": "K Inoki", "year": "2003", "unstructured": "Inoki K, Li Y, Xu T, Guan KL . (2003). Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17: 1829\u20131834.", "journal-title": "Genes Dev"}, {"key": "BFonc2008247_CR70", "doi-asserted-by": "crossref", "first-page": "648", "DOI": "10.1038/ncb839", "volume": "4", "author": "K Inoki", "year": "2002", "unstructured": "Inoki K, Li Y, Zhu T, Wu J, Guan KL . (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4: 648\u2013657.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008247_CR71", "doi-asserted-by": "crossref", "first-page": "46912", "DOI": "10.1074/jbc.C100483200", "volume": "276", "author": "SN Jakobsen", "year": "2001", "unstructured": "Jakobsen SN, Hardie DG, Morrice N, Tornqvist HE . (2001). 5\u2032-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem 276: 46912\u201346916.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR72", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/S1470-2045(07)70411-4", "volume": "9", "author": "J Jozwiak", "year": "2008", "unstructured": "Jozwiak J, Jozwiak S, Wlodarski P . (2008). Possible mechanisms of disease development in tuberous sclerosis. Lancet Oncol 9: 73\u201379.", "journal-title": "Lancet Oncol"}, {"key": "BFonc2008247_CR73", "doi-asserted-by": "crossref", "first-page": "29930", "DOI": "10.1074/jbc.M402591200", "volume": "279", "author": "M Karbowniczek", "year": "2004", "unstructured": "Karbowniczek M, Cash T, Cheung M, Robertson GP, Astrinidis A, Henske EP . (2004). Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent. J Biol Chem 279: 29930\u201329937.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR74", "doi-asserted-by": "crossref", "first-page": "25447", "DOI": "10.1074/jbc.M605273200", "volume": "281", "author": "M Karbowniczek", "year": "2006", "unstructured": "Karbowniczek M, Robertson GP, Henske EP . (2006). Rheb inhibits C-raf activity and B-raf/C-raf heterodimerization. J Biol Chem 281: 25447\u201325456.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR75", "doi-asserted-by": "crossref", "first-page": "615", "DOI": "10.1146/annurev.cellbio.17.1.615", "volume": "17", "author": "R Katso", "year": "2001", "unstructured": "Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD . (2001). Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 17: 615\u2013675.", "journal-title": "Annu Rev Cell Dev Biol"}, {"key": "BFonc2008247_CR76", "doi-asserted-by": "crossref", "first-page": "1043", "DOI": "10.2337/diacare.20.6.1043", "volume": "20", "author": "M Kawanishi", "year": "1997", "unstructured": "Kawanishi M, Tamori Y, Masugi J, Mori H, Ito C, Hansen T et al. (1997). Prevalence of a polymorphism of the phosphatidylinositol 3-kinase p85 alpha regulatory subunit (codon 326 Met \u2192 Ile) in Japanese NIDDM patients. Diabetes Care 20: 1043.", "journal-title": "Diabetes Care"}, {"key": "BFonc2008247_CR77", "first-page": "1700", "volume": "118", "author": "MS Kim", "year": "2008", "unstructured": "Kim MS, Jeong EG, Yoo NJ, Lee SH . (2008). Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. Br J Cancer 118: 1700\u20131711.", "journal-title": "Br J Cancer"}, {"key": "BFonc2008247_CR78", "doi-asserted-by": "crossref", "first-page": "4285", "DOI": "10.1074/jbc.M308383200", "volume": "279", "author": "S Kim", "year": "2004", "unstructured": "Kim S, Domon-Dell C, Kang J, Chung DH, Freund JN, Evers BM . (2004). Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J Biol Chem 279: 4285\u20134291.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR79", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1007/BF01366952", "volume": "122", "author": "AG Knudson", "year": "1996", "unstructured": "Knudson AG . (1996). Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol 122: 135\u2013140.", "journal-title": "J Cancer Res Clin Oncol"}, {"key": "BFonc2008247_CR80", "doi-asserted-by": "crossref", "first-page": "630", "DOI": "10.1038/19328", "volume": "398", "author": "GJ Kops", "year": "1999", "unstructured": "Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM . (1999). Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398: 630\u2013634.", "journal-title": "Nature"}, {"key": "BFonc2008247_CR81", "doi-asserted-by": "crossref", "first-page": "10189", "DOI": "10.1074/jbc.M210837200", "volume": "278", "author": "KS Kovacina", "year": "2003", "unstructured": "Kovacina KS, Park GY, Bae SS, Guzzetta AW, Schaefer E, Birnbaum MJ et al. (2003). Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J Biol Chem 278: 10189\u201310194.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR82", "doi-asserted-by": "crossref", "first-page": "2498", "DOI": "10.1128/MCB.25.6.2498-2510.2005", "volume": "25", "author": "C Kurlawalla-Martinez", "year": "2005", "unstructured": "Kurlawalla-Martinez C, Stiles B, Wang Y, Devaskar SU, Kahn BB, Wu H . (2005). Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol 25: 2498\u20132510.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008247_CR83", "doi-asserted-by": "crossref", "first-page": "39356", "DOI": "10.1074/jbc.M304524200", "volume": "278", "author": "H Lahlou", "year": "2003", "unstructured": "Lahlou H, Saint-Laurent N, Esteve JP, Eychene A, Pradayrol L, Pyronnet S et al. (2003). sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation. J Biol Chem 278: 39356\u201339371.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR84", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.4161/cc.7.5.5416", "volume": "7", "author": "JT Lee", "year": "2008", "unstructured": "Lee JT, Steelman LS, Chappell WH, McCubrey JA . (2008). Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cells. Cell Cycle 7: 631\u2013636.", "journal-title": "Cell Cycle"}, {"key": "BFonc2008247_CR85", "first-page": "2124", "volume": "57", "author": "DM Li", "year": "1997", "unstructured": "Li DM, Sun H . (1997). TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57: 2124\u20132129.", "journal-title": "Cancer Res"}, {"key": "BFonc2008247_CR86", "doi-asserted-by": "crossref", "first-page": "1943", "DOI": "10.1126/science.275.5308.1943", "volume": "275", "author": "J Li", "year": "1997", "unstructured": "Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI et al. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943\u20131947.", "journal-title": "Science"}, {"key": "BFonc2008247_CR87", "doi-asserted-by": "crossref", "first-page": "5160", "DOI": "10.1242/jcs.000133", "volume": "119", "author": "Y Lindsay", "year": "2006", "unstructured": "Lindsay Y, McCoull D, Davidson L, Leslie NR, Fairservice A, Gray A et al. (2006). Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression. J Cell Sci 119: 5160\u20135168.", "journal-title": "J Cell Sci"}, {"key": "BFonc2008247_CR88", "doi-asserted-by": "crossref", "first-page": "11054", "DOI": "10.1158/0008-5472.CAN-07-1263", "volume": "67", "author": "JL Liu", "year": "2007", "unstructured": "Liu JL, Mao Z, LaFortune TA, Alonso MM, Gallick GE, Fueyo J et al. (2007). Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade. Cancer Res 67: 11054\u201311063.", "journal-title": "Cancer Res"}, {"key": "BFonc2008247_CR89", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1016/j.drup.2007.11.003", "volume": "11", "author": "J Lopiccolo", "year": "2007", "unstructured": "Lopiccolo J, Blumenthal GM, Bernstein WB, Dennis PA . (2007). Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat 11: 32\u201350.", "journal-title": "Drug Resist Updat"}, {"key": "BFonc2008247_CR90", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1083/jcb.200503088", "volume": "170", "author": "J Luo", "year": "2005", "unstructured": "Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC . (2005a). The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J Cell Biol 170: 455\u2013464.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008247_CR91", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1016/S1535-6108(03)00248-4", "volume": "4", "author": "J Luo", "year": "2003", "unstructured": "Luo J, Manning BD, Cantley LC . (2003). Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4: 257\u2013262.", "journal-title": "Cancer Cell"}, {"key": "BFonc2008247_CR92", "doi-asserted-by": "crossref", "first-page": "10238", "DOI": "10.1073/pnas.0504378102", "volume": "102", "author": "J Luo", "year": "2005", "unstructured": "Luo J, Sobkiw CL, Logsdon NM, Watt JM, Signoretti S, O'Connell F et al. (2005b). Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/\u2212 mice by the p85 regulatory subunits of phosphoinositide 3-kinase. Proc Natl Acad Sci USA 102: 10238\u201310243.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR93", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1016/j.cell.2005.02.031", "volume": "121", "author": "L Ma", "year": "2005", "unstructured": "Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP . (2005a). Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121: 179\u2013193.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR94", "doi-asserted-by": "crossref", "first-page": "1779", "DOI": "10.1101/gad.1314405", "volume": "19", "author": "L Ma", "year": "2005", "unstructured": "Ma L, Teruya-Feldstein J, Behrendt N, Chen Z, Noda T, Hino O et al. (2005b). Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev 19: 1779\u20131786.", "journal-title": "Genes Dev"}, {"key": "BFonc2008247_CR95", "doi-asserted-by": "crossref", "first-page": "7106", "DOI": "10.1158/0008-5472.CAN-06-4798", "volume": "67", "author": "L Ma", "year": "2007", "unstructured": "Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D et al. (2007). Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Res 67: 7106\u20137112.", "journal-title": "Cancer Res"}, {"key": "BFonc2008247_CR96", "doi-asserted-by": "crossref", "first-page": "33490", "DOI": "10.1074/jbc.M204042200", "volume": "277", "author": "S Mabuchi", "year": "2002", "unstructured": "Mabuchi S, Ohmichi M, Kimura A, Hisamoto K, Hayakawa J, Nishio Y et al. (2002). Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel. J Biol Chem 277: 33490\u201333500.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR97", "doi-asserted-by": "crossref", "first-page": "13375", "DOI": "10.1074/jbc.273.22.13375", "volume": "273", "author": "T Maehama", "year": "1998", "unstructured": "Maehama T, Dixon JE . (1998). The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375\u201313378.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR98", "doi-asserted-by": "crossref", "first-page": "594", "DOI": "10.1038/nm1052", "volume": "10", "author": "PK Majumder", "year": "2004", "unstructured": "Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM et al. (2004). mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 10: 594\u2013601.", "journal-title": "Nat Med"}, {"key": "BFonc2008247_CR99", "doi-asserted-by": "crossref", "first-page": "7841", "DOI": "10.1073/pnas.1232229100", "volume": "100", "author": "PK Majumder", "year": "2003", "unstructured": "Majumder PK, Yeh JJ, George DJ, Febbo PG, Kum J, Xue Q et al. (2003). Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc Natl Acad Sci USA 100: 7841\u20137846.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR100", "doi-asserted-by": "crossref", "first-page": "665", "DOI": "10.4161/cc.7.5.5485", "volume": "7", "author": "D Malanga", "year": "2008", "unstructured": "Malanga D, Scrima M, De Marco C, Fabiani F, De Rosa N, De Gisi S et al. (2008). Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. Cell Cycle 7: 665\u2013669.", "journal-title": "Cell Cycle"}, {"key": "BFonc2008247_CR101", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1083/jcb.200408161", "volume": "167", "author": "BD Manning", "year": "2004", "unstructured": "Manning BD . (2004). Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 167: 399\u2013403.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008247_CR102", "doi-asserted-by": "crossref", "first-page": "1261", "DOI": "10.1016/j.cell.2007.06.009", "volume": "129", "author": "BD Manning", "year": "2007", "unstructured": "Manning BD, Cantley LC . (2007). AKT/PKB signaling: navigating downstream. Cell 129: 1261\u20131274.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR103", "doi-asserted-by": "crossref", "first-page": "1773", "DOI": "10.1101/gad.1314605", "volume": "19", "author": "BD Manning", "year": "2005", "unstructured": "Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC . (2005). Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 19: 1773\u20131778.", "journal-title": "Genes Dev"}, {"key": "BFonc2008247_CR104", "doi-asserted-by": "crossref", "first-page": "11598", "DOI": "10.1073/pnas.181181198", "volume": "98", "author": "LD Mayo", "year": "2001", "unstructured": "Mayo LD, Donner DB . (2001). A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 98: 11598\u201311603.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR105", "doi-asserted-by": "crossref", "first-page": "31099", "DOI": "10.1074/jbc.M111974200", "volume": "277", "author": "K Moelling", "year": "2002", "unstructured": "Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M . (2002). Regulation of Raf-Akt cross-talk. J Biol Chem 277: 31099\u201331106.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR106", "doi-asserted-by": "crossref", "first-page": "15982", "DOI": "10.1074/jbc.274.23.15982", "volume": "274", "author": "J Nakae", "year": "1999", "unstructured": "Nakae J, Park BC, Accili D . (1999). Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway. J Biol Chem 274: 15982\u201315985.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR107", "doi-asserted-by": "crossref", "first-page": "20517", "DOI": "10.1073/pnas.0610290104", "volume": "104", "author": "YG Ni", "year": "2007", "unstructured": "Ni YG, Wang N, Cao DJ, Sachan N, Morris DJ, Gerard RD et al. (2007). FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci USA 104: 20517\u201320522.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR108", "doi-asserted-by": "crossref", "first-page": "14238", "DOI": "10.1073/pnas.0506925102", "volume": "102", "author": "T Nobukuni", "year": "2005", "unstructured": "Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY, Gulati P et al. (2005). Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci USA 102: 14238\u201314243.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR109", "doi-asserted-by": "crossref", "first-page": "1500", "DOI": "10.1158/0008-5472.CAN-05-2925", "volume": "66", "author": "KE O'Reilly", "year": "2006", "unstructured": "O'Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D et al. (2006). mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 66: 1500\u20131508.", "journal-title": "Cancer Res"}, {"key": "BFonc2008247_CR110", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.1016/j.molcel.2007.12.023", "volume": "29", "author": "U Ozcan", "year": "2008", "unstructured": "Ozcan U, Ozcan L, Yilmaz E, Duvel K, Sahin M, Manning BD et al. (2008). Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell 29: 541\u2013551.", "journal-title": "Mol Cell"}, {"key": "BFonc2008247_CR111", "doi-asserted-by": "crossref", "first-page": "4640", "DOI": "10.1073/pnas.051042298", "volume": "98", "author": "ON Ozes", "year": "2001", "unstructured": "Ozes ON, Akca H, Mayo LD, Gustin JA, Maehama T, Dixon JE et al. (2001). A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci USA 98: 4640\u20134645.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR112", "doi-asserted-by": "crossref", "first-page": "1203", "DOI": "10.1038/nm1636", "volume": "13", "author": "T Palomero", "year": "2007", "unstructured": "Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al. (2007). Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13: 1203\u20131210.", "journal-title": "Nat Med"}, {"key": "BFonc2008247_CR113", "doi-asserted-by": "crossref", "first-page": "3050", "DOI": "10.1038/sj.emboj.7601763", "volume": "26", "author": "EA Papakonstanti", "year": "2007", "unstructured": "Papakonstanti EA, Ridley AJ, Vanhaesebroeck B . (2007). The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN. EMBO J 26: 3050\u20133061.", "journal-title": "EMBO J"}, {"key": "BFonc2008247_CR114", "doi-asserted-by": "crossref", "first-page": "15641", "DOI": "10.1074/jbc.M208984200", "volume": "278", "author": "L Pirola", "year": "2003", "unstructured": "Pirola L, Bonnafous S, Johnston AM, Chaussade C, Portis F, Van Obberghen E . (2003). Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells. J Biol Chem 278 15641\u201315651.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR115", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1038/ncb840", "volume": "4", "author": "CJ Potter", "year": "2002", "unstructured": "Potter CJ, Pedraza LG, Xu T . (2002). Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4: 658\u2013665.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008247_CR116", "doi-asserted-by": "crossref", "first-page": "2627", "DOI": "10.1101/gad.239102", "volume": "16", "author": "T Radimerski", "year": "2002", "unstructured": "Radimerski T, Montagne J, Hemmings-Mieszczak M, Thomas G . (2002). Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Genes Dev 16: 2627\u20132632.", "journal-title": "Genes Dev"}, {"key": "BFonc2008247_CR117", "doi-asserted-by": "crossref", "first-page": "2902", "DOI": "10.4161/cc.6.23.4996", "volume": "6", "author": "AR Ramjaun", "year": "2007", "unstructured": "Ramjaun AR, Downward J . (2007). Ras and phosphoinositide 3-kinase: partners in development and tumorigenesis. Cell Cycle 6: 2902\u20132905.", "journal-title": "Cell Cycle"}, {"key": "BFonc2008247_CR118", "doi-asserted-by": "crossref", "first-page": "1761", "DOI": "10.1038/sj.emboj.7600193", "volume": "23", "author": "B Raught", "year": "2004", "unstructured": "Raught B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL et al. (2004). Phosphorylation of eukaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 23: 1761\u20131769.", "journal-title": "EMBO J"}, {"key": "BFonc2008247_CR119", "doi-asserted-by": "crossref", "first-page": "17179", "DOI": "10.1074/jbc.274.24.17179", "volume": "274", "author": "G Rena", "year": "1999", "unstructured": "Rena G, Guo S, Cichy SC, Unterman TG, Cohen P . (1999). Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274: 17179\u201317183.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR120", "doi-asserted-by": "crossref", "first-page": "33630", "DOI": "10.1074/jbc.M105322200", "volume": "276", "author": "HP Reusch", "year": "2001", "unstructured": "Reusch HP, Zimmermann S, Schaefer M, Paul M, Moelling K . (2001). Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells. J Biol Chem 276: 33630\u201333637.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR121", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1016/S0092-8674(00)80226-3", "volume": "89", "author": "P Rodriguez-Viciana", "year": "1997", "unstructured": "Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P et al. (1997). Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89: 457\u2013467.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR122", "doi-asserted-by": "crossref", "first-page": "1738", "DOI": "10.1126/science.286.5445.1738", "volume": "286", "author": "C Rommel", "year": "1999", "unstructured": "Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K et al. (1999). Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286: 1738\u20131741.", "journal-title": "Science"}, {"key": "BFonc2008247_CR123", "doi-asserted-by": "crossref", "first-page": "13489", "DOI": "10.1073/pnas.0405659101", "volume": "101", "author": "PP Roux", "year": "2004", "unstructured": "Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J . (2004). Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci USA 101: 13489\u201313494.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR124", "doi-asserted-by": "crossref", "first-page": "14056", "DOI": "10.1074/jbc.M700906200", "volume": "282", "author": "PP Roux", "year": "2007", "unstructured": "Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, Taunton J et al. (2007). RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem 282: 14056\u201314064.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR125", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/0092-8674(94)90570-3", "volume": "78", "author": "DM Sabatini", "year": "1994", "unstructured": "Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH . (1994). RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78: 35\u201343.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR126", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1016/j.cell.2008.04.013", "volume": "133", "author": "L Salmena", "year": "2008", "unstructured": "Salmena L, Carracedo A, Pandolfi PP . (2008). Tenets of PTEN tumor suppression. Cell 133: 403\u2013414.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR127", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1128/MCB.01318-07", "volume": "28", "author": "C Sampaio", "year": "2008", "unstructured": "Sampaio C, Dance M, Montagner A, Edouard T, Malet N, Perret B et al. (2008). Signal strength dictates phosphoinositide 3-kinase contribution to Ras/extracellular signal-regulated kinase 1 and 2 activation via differential Gab1/Shp2 recruitment: consequences for resistance to epidermal growth factor receptor inhibition. Mol Cell Biol 28: 587\u2013600.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008247_CR128", "doi-asserted-by": "crossref", "first-page": "554", "DOI": "10.1126/science.1096502", "volume": "304", "author": "Y Samuels", "year": "2004", "unstructured": "Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.", "journal-title": "Science"}, {"key": "BFonc2008247_CR129", "doi-asserted-by": "crossref", "first-page": "903", "DOI": "10.1016/j.molcel.2007.03.003", "volume": "25", "author": "Y Sancak", "year": "2007", "unstructured": "Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E et al. (2007). PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25: 903\u2013915.", "journal-title": "Mol Cell"}, {"key": "BFonc2008247_CR130", "doi-asserted-by": "crossref", "first-page": "14599", "DOI": "10.1074/jbc.C300063200", "volume": "278", "author": "H Sano", "year": "2003", "unstructured": "Sano H, Kane S, Sano E, Miinea CP, Asara JM, Lane WS et al. (2003). Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 278: 14599\u201314602.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR131", "doi-asserted-by": "crossref", "first-page": "1296", "DOI": "10.1016/j.cub.2004.06.054", "volume": "14", "author": "DD Sarbassov", "year": "2004", "unstructured": "Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H et al. (2004). Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14: 1296\u20131302.", "journal-title": "Curr Biol"}, {"key": "BFonc2008247_CR132", "doi-asserted-by": "crossref", "first-page": "1098", "DOI": "10.1126/science.1106148", "volume": "307", "author": "DD Sarbassov", "year": "2005", "unstructured": "Sarbassov DD, Guertin DA, Ali SM, Sabatini DM . (2005). Phosphorylation and regulation of Akt/PKB by the rictor\u2013mTOR complex. Science 307: 1098\u20131101.", "journal-title": "Science"}, {"key": "BFonc2008247_CR133", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1083/jcb.200406177", "volume": "167", "author": "AT Sasaki", "year": "2004", "unstructured": "Sasaki AT, Chun C, Takeda K, Firtel RA . (2004). Localized Ras signaling at the leading edge regulates PI3K, cell polarity, and directional cell movement. J Cell Biol 167: 505\u2013518.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008247_CR134", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1083/jcb.200611138", "volume": "178", "author": "AT Sasaki", "year": "2007", "unstructured": "Sasaki AT, Janetopoulos C, Lee S, Charest PG, Takeda K, Sundheimer LW et al. (2007). G protein-independent Ras/PI3K/F-actin circuit regulates basic cell motility. J Cell Biol 178: 185\u2013191.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008247_CR135", "doi-asserted-by": "crossref", "first-page": "33759", "DOI": "10.1074/jbc.M402055200", "volume": "279", "author": "S Sato", "year": "2004", "unstructured": "Sato S, Fujita N, Tsuruo T . (2004). Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathway. J Biol Chem 279: 33759\u201333767.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR136", "doi-asserted-by": "crossref", "first-page": "991", "DOI": "10.1038/sj.onc.1207278", "volume": "23", "author": "B Schafer", "year": "2004", "unstructured": "Schafer B, Gschwind A, Ullrich A . (2004). Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23: 991\u2013999.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR137", "doi-asserted-by": "crossref", "first-page": "1653", "DOI": "10.1038/sj.onc.1204181", "volume": "20", "author": "WF Schwindinger", "year": "2001", "unstructured": "Schwindinger WF, Robishaw JD . (2001). Heterotrimeric G-protein betagamma-dimers in growth and differentiation. Oncogene 20: 1653\u20131660.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR138", "doi-asserted-by": "crossref", "first-page": "1650", "DOI": "10.1016/j.cub.2004.08.026", "volume": "14", "author": "OJ Shah", "year": "2004", "unstructured": "Shah OJ, Wang Z, Hunter T . (2004). Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14: 1650\u20131656.", "journal-title": "Curr Biol"}, {"key": "BFonc2008247_CR139", "doi-asserted-by": "crossref", "first-page": "2781", "DOI": "10.1038/sj.emboj.7601166", "volume": "25", "author": "D Shahbazian", "year": "2006", "unstructured": "Shahbazian D, Roux PP, Mieulet V, Cohen MS, Raught B, Taunton J et al. (2006). The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J 25: 2781\u20132791.", "journal-title": "EMBO J"}, {"key": "BFonc2008247_CR140", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1016/S0092-8674(00)81780-8", "volume": "95", "author": "V Stambolic", "year": "1998", "unstructured": "Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T et al. (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29\u201339.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR141", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1038/ng0497-356", "volume": "15", "author": "PA Steck", "year": "1997", "unstructured": "Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH et al. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356\u2013362.", "journal-title": "Nat Genet"}, {"key": "BFonc2008247_CR142", "doi-asserted-by": "crossref", "first-page": "2082", "DOI": "10.1073/pnas.0308617100", "volume": "101", "author": "B Stiles", "year": "2004", "unstructured": "Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ et al. (2004). Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci USA 101: 2082\u20132087.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR143", "doi-asserted-by": "crossref", "first-page": "7052", "DOI": "10.1158/0008-5472.CAN-05-0917", "volume": "65", "author": "SY Sun", "year": "2005", "unstructured": "Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, Fu H et al. (2005). Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res 65: 7052\u20137058.", "journal-title": "Cancer Res"}, {"key": "BFonc2008247_CR144", "doi-asserted-by": "crossref", "first-page": "11836", "DOI": "10.1073/pnas.96.21.11836", "volume": "96", "author": "H Takaishi", "year": "1999", "unstructured": "Takaishi H, Konishi H, Matsuzaki H, Ono Y, Shirai Y, Saito N et al. (1999). Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci USA 96: 11836\u201311841.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR145", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1182/blood-2007-03-080796", "volume": "111", "author": "J Tamburini", "year": "2008", "unstructured": "Tamburini J, Chapuis N, Bardet V, Park S, Sujobert P, Willems L et al. (2008). Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways. Blood 111: 379\u2013382.", "journal-title": "Blood"}, {"key": "BFonc2008247_CR146", "doi-asserted-by": "crossref", "first-page": "16741", "DOI": "10.1074/jbc.274.24.16741", "volume": "274", "author": "ED Tang", "year": "1999", "unstructured": "Tang ED, Nunez G, Barr FG, Guan KL . (1999). Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274: 16741\u201316746.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR147", "doi-asserted-by": "crossref", "first-page": "1259", "DOI": "10.1016/S0960-9822(03)00506-2", "volume": "13", "author": "AR Tee", "year": "2003", "unstructured": "Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J . (2003). Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13: 1259\u20131268.", "journal-title": "Curr Biol"}, {"key": "BFonc2008247_CR148", "doi-asserted-by": "crossref", "first-page": "993", "DOI": "10.1074/jbc.M009134200", "volume": "276", "author": "J Torres", "year": "2001", "unstructured": "Torres J, Pulido R . (2001). The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem 276: 993\u2013998.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR149", "doi-asserted-by": "crossref", "first-page": "14056", "DOI": "10.1073/pnas.0706517104", "volume": "104", "author": "F Tremblay", "year": "2007", "unstructured": "Tremblay F, Brule S, Hee Um S, Li Y, Masuda K, Roden M et al. (2007). Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci USA 104: 14056\u201314061.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008247_CR150", "first-page": "38052", "volume": "276", "author": "F Tremblay", "year": "2001", "unstructured": "Tremblay F, Marette A . (2001). Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 276: 38052\u201338060.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR151", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1038/nature04809", "volume": "441", "author": "LC Trotman", "year": "2006", "unstructured": "Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP . (2006). Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441: 523\u2013527.", "journal-title": "Nature"}, {"key": "BFonc2008247_CR152", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/j.cell.2006.11.040", "volume": "128", "author": "LC Trotman", "year": "2007", "unstructured": "Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H et al. (2007). Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128: 141\u2013156.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR153", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1128/MCB.26.1.63-76.2006", "volume": "26", "author": "A Tzatsos", "year": "2006", "unstructured": "Tzatsos A, Kandror KV . (2006). Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol 26: 63\u201376.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008247_CR154", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1038/ncb1547", "volume": "9", "author": "E Vander Haar", "year": "2007", "unstructured": "Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH . (2007). Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9: 316\u2013323.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008247_CR155", "doi-asserted-by": "crossref", "first-page": "10343", "DOI": "10.1158/0008-5472.CAN-07-1827", "volume": "67", "author": "KM Vasudevan", "year": "2007", "unstructured": "Vasudevan KM, Burikhanov R, Goswami A, Rangnekar VM . (2007). Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras. Cancer Res 67: 10343\u201310350.", "journal-title": "Cancer Res"}, {"key": "BFonc2008247_CR156", "doi-asserted-by": "crossref", "first-page": "1007", "DOI": "10.1128/MCB.24.3.1007-1021.2004", "volume": "24", "author": "KM Vasudevan", "year": "2004", "unstructured": "Vasudevan KM, Gurumurthy S, Rangnekar VM . (2004). Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol 24: 1007\u20131021.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008247_CR157", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.7164/antibiotics.28.721", "volume": "28", "author": "C Vezina", "year": "1975", "unstructured": "Vezina C, Kudelski A, Sehgal SN . (1975). Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 28: 721\u2013726.", "journal-title": "J Antibiot (Tokyo)"}, {"key": "BFonc2008247_CR158", "doi-asserted-by": "crossref", "first-page": "555", "DOI": "10.1016/j.ccr.2007.04.021", "volume": "11", "author": "I Vivanco", "year": "2007", "unstructured": "Vivanco I, Palaskas N, Tran C, Finn SP, Getz G, Kennedy NJ et al. (2007). Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. Cancer Cell 11: 555\u2013569.", "journal-title": "Cancer Cell"}, {"key": "BFonc2008247_CR159", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1038/nrc839", "volume": "2", "author": "I Vivanco", "year": "2002", "unstructured": "Vivanco I, Sawyers CL . (2002). The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489\u2013501.", "journal-title": "Nat Rev Cancer"}, {"key": "BFonc2008247_CR160", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1042/bj20031839", "volume": "379", "author": "SM Walker", "year": "2004", "unstructured": "Walker SM, Leslie NR, Perera NM, Batty IH, Downes CP . (2004). The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Biochem J 379: 301\u2013307.", "journal-title": "Biochem J"}, {"key": "BFonc2008247_CR161", "doi-asserted-by": "crossref", "first-page": "1932", "DOI": "10.1038/sj.onc.1209990", "volume": "26", "author": "X Wan", "year": "2007", "unstructured": "Wan X, Harkavy B, Shen N, Grohar P, Helman LJ . (2007). Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26: 1932\u20131940.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR162", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1038/sj.onc.1209004", "volume": "25", "author": "Q Wang", "year": "2006", "unstructured": "Wang Q, Zhou Y, Wang X, Evers BM . (2006). Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase. Oncogene 25: 43\u201350.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR163", "doi-asserted-by": "crossref", "first-page": "4370", "DOI": "10.1093/emboj/20.16.4370", "volume": "20", "author": "X Wang", "year": "2001", "unstructured": "Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG . (2001). Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J 20: 4370\u20134379.", "journal-title": "EMBO J"}, {"key": "BFonc2008247_CR164", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1016/j.cell.2006.11.039", "volume": "128", "author": "X Wang", "year": "2007", "unstructured": "Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z et al. (2007). NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128: 129\u2013139.", "journal-title": "Cell"}, {"key": "BFonc2008247_CR165", "doi-asserted-by": "crossref", "first-page": "3077", "DOI": "10.1158/0008-5472.CAN-07-3293", "volume": "68", "author": "IB Weinstein", "year": "2008", "unstructured": "Weinstein IB, Joe A . (2008). Oncogene addiction. Cancer Res 68: 3077\u20133080. (discussion 3080)", "journal-title": "Cancer Res"}, {"key": "BFonc2008247_CR166", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1016/S0014-5793(03)00454-X", "volume": "546", "author": "HC Welch", "year": "2003", "unstructured": "Welch HC, Coadwell WJ, Stephens LR, Hawkins PT . (2003). Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett 546: 93\u201397.", "journal-title": "FEBS Lett"}, {"key": "BFonc2008247_CR167", "doi-asserted-by": "crossref", "first-page": "7709", "DOI": "10.1038/sj.onc.1210580", "volume": "26", "author": "V Wells", "year": "2007", "unstructured": "Wells V, Downward J, Mallucci L . (2007). Functional inhibition of PI3K by the betaGBP molecule suppresses Ras-MAPK signalling to block cell proliferation. Oncogene 26: 7709\u20137714.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR168", "doi-asserted-by": "crossref", "first-page": "4279", "DOI": "10.1128/MCB.19.6.4279", "volume": "19", "author": "S Wennstrom", "year": "1999", "unstructured": "Wennstrom S, Downward J . (1999). Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor. Mol Cell Biol 19: 4279\u20134288.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008247_CR169", "doi-asserted-by": "crossref", "first-page": "1135", "DOI": "10.1128/MCB.25.3.1135-1145.2005", "volume": "25", "author": "N Wijesekara", "year": "2005", "unstructured": "Wijesekara N, Konrad D, Eweida M, Jefferies C, Liadis N, Giacca A et al. (2005). Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol Cell Biol 25: 1135\u20131145.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008247_CR170", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1016/j.neulet.2006.05.018", "volume": "404", "author": "DN Wu", "year": "2006", "unstructured": "Wu DN, Pei DS, Wang Q, Zhang GY . (2006). Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat hippocampus. Neurosci Lett 404: 98\u2013102.", "journal-title": "Neurosci Lett"}, {"key": "BFonc2008247_CR171", "doi-asserted-by": "crossref", "first-page": "28258", "DOI": "10.1074/jbc.M303318200", "volume": "278", "author": "W Wu", "year": "2003", "unstructured": "Wu W, Wang X, Zhang W, Reed W, Samet JM, Whang YE et al. (2003). Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. J Biol Chem 278: 28258\u201328263.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR172", "doi-asserted-by": "crossref", "first-page": "3507", "DOI": "10.1074/jbc.M610141200", "volume": "282", "author": "D Xia", "year": "2007", "unstructured": "Xia D, Srinivas H, Ahn YH, Sethi G, Sheng X, Yung WK et al. (2007). Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. J Biol Chem 282: 3507\u20133519.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR173", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/S1388-1981(02)00144-0", "volume": "1582", "author": "A Yart", "year": "2002", "unstructured": "Yart A, Chap H, Raynal P . (2002). Phosphoinositide 3-kinases in lysophosphatidic acid signaling: regulation and cross-talk with the Ras/mitogen-activated protein kinase pathway. Biochim Biophys Acta 1582: 107\u2013111.", "journal-title": "Biochim Biophys Acta"}, {"key": "BFonc2008247_CR174", "doi-asserted-by": "crossref", "first-page": "8856", "DOI": "10.1074/jbc.M006966200", "volume": "276", "author": "A Yart", "year": "2001", "unstructured": "Yart A, Laffargue M, Mayeux P, Chretien S, Peres C, Tonks N et al. (2001). A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor. J Biol Chem 276: 8856\u20138864.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR175", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1128/MCB.17.2.921", "volume": "17", "author": "WM Yee", "year": "1997", "unstructured": "Yee WM, Worley PF . (1997). Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals. Mol Cell Biol 17: 921\u2013933.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008247_CR176", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1038/nature04703", "volume": "441", "author": "OH Yilmaz", "year": "2006", "unstructured": "Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H et al. (2006). Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441: 475\u2013482.", "journal-title": "Nature"}, {"key": "BFonc2008247_CR177", "unstructured": "Yuan TL, Cantley LC . (2008). P13K pathway alterations in cancer: variations on a theme. Oncogene (in press).", "DOI": "10.1038/onc.2008.245", "doi-asserted-by": "crossref"}, {"key": "BFonc2008247_CR178", "doi-asserted-by": "crossref", "first-page": "23432", "DOI": "10.1074/jbc.M302674200", "volume": "278", "author": "ZQ Yuan", "year": "2003", "unstructured": "Yuan ZQ, Feldman RI, Sussman GE, Coppola D, Nicosia SV, Cheng JQ . (2003). AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol Chem 278: 23432\u201323440.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR179", "doi-asserted-by": "crossref", "first-page": "1016", "DOI": "10.1128/MCB.22.4.1016-1026.2002", "volume": "22", "author": "R Zhande", "year": "2002", "unstructured": "Zhande R, Mitchell JJ, Wu J, Sun XJ . (2002). Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol Cell Biol 22: 1016\u20131026.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008247_CR180", "doi-asserted-by": "crossref", "first-page": "31620", "DOI": "10.1074/jbc.M102808200", "volume": "276", "author": "BH Zhang", "year": "2001", "unstructured": "Zhang BH, Tang ED, Zhu T, Greenberg ME, Vojtek AB, Guan KL . (2001). Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf. J Biol Chem 276: 31620\u201331626.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008247_CR181", "doi-asserted-by": "crossref", "first-page": "730", "DOI": "10.1172/JCI28984", "volume": "117", "author": "H Zhang", "year": "2007", "unstructured": "Zhang H, Bajraszewski N, Wu E, Wang H, Moseman AP, Dabora SL et al. (2007). PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J Clin Invest 117: 730\u2013738.", "journal-title": "J Clin Invest"}, {"key": "BFonc2008247_CR182", "doi-asserted-by": "crossref", "first-page": "1223", "DOI": "10.1172/JCI200317222", "volume": "112", "author": "H Zhang", "year": "2003", "unstructured": "Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N et al. (2003a). Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223\u20131233.", "journal-title": "J Clin Invest"}, {"key": "BFonc2008247_CR183", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1016/j.molcel.2006.09.019", "volume": "24", "author": "HH Zhang", "year": "2006", "unstructured": "Zhang HH, Lipovsky AI, Dibble CC, Sahin M, Manning BD . (2006a). S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol Cell 24: 185\u2013197.", "journal-title": "Mol Cell"}, {"key": "BFonc2008247_CR184", "doi-asserted-by": "crossref", "first-page": "518", "DOI": "10.1038/nature04747", "volume": "441", "author": "J Zhang", "year": "2006", "unstructured": "Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT et al. (2006b). PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441: 518\u2013522.", "journal-title": "Nature"}, {"key": "BFonc2008247_CR185", "doi-asserted-by": "crossref", "first-page": "3954", "DOI": "10.1038/sj.onc.1208548", "volume": "24", "author": "R Zhang", "year": "2005", "unstructured": "Zhang R, Luo D, Miao R, Bai L, Ge Q, Sessa WC et al. (2005). Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. Oncogene 24: 3954\u20133963.", "journal-title": "Oncogene"}, {"key": "BFonc2008247_CR186", "doi-asserted-by": "crossref", "first-page": "578", "DOI": "10.1038/ncb999", "volume": "5", "author": "Y Zhang", "year": "2003", "unstructured": "Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D . (2003b). Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 5: 578\u2013581.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008247_CR187", "unstructured": "Zhao L, Vogt PK . (2008). Class I P13K in oncogenic cellular transformation. Oncogene (in press).", "DOI": "10.1038/onc.2008.244", "doi-asserted-by": "crossref"}, {"key": "BFonc2008247_CR188", "doi-asserted-by": "crossref", "first-page": "1741", "DOI": "10.1126/science.286.5445.1741", "volume": "286", "author": "S Zimmermann", "year": "1999", "unstructured": "Zimmermann S, Moelling K . (1999). Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286: 1741\u20131744.", "journal-title": "Science"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/onc2008247.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2008247", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2008247.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T16:51:50Z", "timestamp": 1555606310000}, "score": 67.84908, "issued": {"date-parts": [[2008, 9]]}, "references-count": 188, "journal-issue": {"published-print": {"date-parts": [[2008, 9]]}, "issue": "41"}, "alternative-id": ["BFonc2008247"], "URL": "http://dx.doi.org/10.1038/onc.2008.247", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}], "subject": ["Genetics", "Cancer Research", "Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T20:56:18Z", "timestamp": 1575492978216}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2019, 7, 1]]}, "DOI": "10.1158/1538-7445.am2019-4298", "type": "proceedings-article", "created": {"date-parts": [[2019, 8, 7]], "date-time": "2019-08-07T22:17:45Z", "timestamp": 1565216265000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 4298: Comparative inhibitory effect of different Egyptian Withania somnifera root extracts on PTEN/PI3K/AKT signaling pathway in HepG2 cell line"], "prefix": "10.1158", "author": [{"given": "Nahla A.", "family": "Elzefzafy", "sequence": "first", "affiliation": []}, {"given": "Amira", "family": "Zaky", "sequence": "additional", "affiliation": []}, {"given": "Wafaa A.", "family": "Ahmed", "sequence": "additional", "affiliation": []}, {"given": "Ahmad", "family": "Bassiouny", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2019, 7, 1]]}, "event": {"name": "Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA"}, "container-title": ["Molecular and Cellular Biology / Genetics"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2019-4298", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 7]], "date-time": "2019-08-07T22:19:02Z", "timestamp": 1565216342000}, "score": 25.016714, "issued": {"date-parts": [[2019, 7, 1]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2019-4298"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2019-4298"}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T02:37:13Z", "timestamp": 1576809433653}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "15_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2016, 5, 20]]}, "DOI": "10.1200/jco.2016.34.15_suppl.5572", "type": "journal-article", "created": {"date-parts": [[2018, 9, 6]], "date-time": "2018-09-06T16:30:50Z", "timestamp": 1536251450000}, "page": "5572-5572", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Somatic alterations in the PTEN-PI3K-AKT-mTOR pathway in a cohort of 379 ovarian cancer patients."], "prefix": "10.1200", "volume": "34", "author": [{"given": "Elizabeth", "family": "Stover", "sequence": "first", "affiliation": [{"name": "Dana-Farber Cancer Institute, Boston, MA;"}]}, {"given": "Levi A.", "family": "Garraway", "sequence": "additional", "affiliation": [{"name": "Dana-Farber Cancer Institute, Boston, MA;"}]}, {"given": "Ursula A.", "family": "Matulonis", "sequence": "additional", "affiliation": [{"name": "Dana-Farber Cancer Institute, Boston, MA;"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.5572", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:42:13Z", "timestamp": 1574890933000}, "score": 25.016714, "issued": {"date-parts": [[2016, 5, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 5, 20]]}, "issue": "15_suppl"}, "alternative-id": ["10.1200/JCO.2016.34.15_suppl.5572"], "URL": "http://dx.doi.org/10.1200/jco.2016.34.15_suppl.5572", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T16:31:10Z", "timestamp": 1574440270733}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 6, 1]], "date-time": "2010-06-01T00:00:00Z", "timestamp": 1275350400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2010, 6]]}, "DOI": "10.1016/s1359-6349(10)71357-4", "type": "journal-article", "created": {"date-parts": [[2010, 6, 29]], "date-time": "2010-06-29T08:24:07Z", "timestamp": 1277799847000}, "page": "142", "source": "Crossref", "is-referenced-by-count": 0, "title": ["556 PTEN can suppress NSCLC invasion through PI3K/AKT/NFkB pathway"], "prefix": "10.1016", "volume": "8", "author": [{"given": "H.", "family": "Akca", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Demiray", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359634910713574?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359634910713574?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 10]], "date-time": "2018-12-10T04:21:32Z", "timestamp": 1544415692000}, "score": 24.982588, "issued": {"date-parts": [[2010, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 6]]}, "issue": "5"}, "alternative-id": ["S1359634910713574"], "URL": "http://dx.doi.org/10.1016/s1359-6349(10)71357-4", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:47:06Z", "timestamp": 1574282826207}, "reference-count": 45, "publisher": "Portland Press Ltd.", "issue": "2", "content-domain": {"domain": ["portlandpress.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2007, 4, 1]]}, "abstract": "<jats:p>PTEN (phosphatase and tensin homologue deleted on chromosome 10) is an important tumour-suppressor gene that encodes a 3-phosphatase. The major substrate of PTEN is PIP3 (phosphatidylinositol 3,4,5-trisphosphate) generated by the action of PI3Ks (phosphoinositide 3-kinases). Hereditary mutation of PTEN causes tumour-susceptibility diseases such as Cowden disease. We used the Cre-loxP system to generate an endothelial cell-specific mutation of PTEN in mice. Heterozygous mutation of PTEN in endothelial cells enhances postnatal neovascularization, including tumour angiogenesis necessary for tumour growth. This observation suggests that Cowden disease patients are not only at risk for additional tumorigenic mutations due to complete loss of PTEN function, but may also experience accelerated growth of incipient tumours due to enhanced angiogenesis. Homozygous mutation of Pten in murine endothelial cells impairs cardiovascular morphogenesis and is embryonic lethal due to endothelial cell hyperproliferation and impaired vascular remodelling. Additional homozygous mutation of p85\u03b1, the regulatory subunit of class IA PI3Ks, or p110\u03b3, the catalytic subunit of the sole class IB PI3K, led to a partial rescue of all phenotypes in our PTEN-deficient mice. Thus inhibition of the PI3K pathway, including the targeting of PI3K\u03b3, may be an attractive therapeutic strategy for the treatment of various malignancies.</jats:p>", "DOI": "10.1042/bst0350172", "type": "journal-article", "created": {"date-parts": [[2007, 3, 21]], "date-time": "2007-03-21T13:38:36Z", "timestamp": 1174484316000}, "page": "172-176", "update-policy": "http://dx.doi.org/10.1042/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Role of PTEN/PI3K pathway in endothelial cells"], "prefix": "10.1042", "volume": "35", "author": [{"given": "A.", "family": "Suzuki", "sequence": "first", "affiliation": [{"name": "Department of Molecular Biology, Akita University School of Medicine, Akita 010-8543, Japan"}]}, {"given": "K.", "family": "Hamada", "sequence": "additional", "affiliation": [{"name": "Department of Molecular Biology, Akita University School of Medicine, Akita 010-8543, Japan"}]}, {"given": "T.", "family": "Sasaki", "sequence": "additional", "affiliation": [{"name": "Department of Microbiology, Akita University School of Medicine, Akita 010-8543, Japan"}]}, {"given": "T.W.", "family": "Mak", "sequence": "additional", "affiliation": [{"name": "The Campbell Family Institute for Breast Cancer Research, Princess Margaret Hospital, Toronto, ON, Canada M5G 2M9"}, {"name": "Departments of Immunology and Medical Biophysics, University of Toronto, Toronto, ON, Canada M5G 2C1"}]}, {"given": "T.", "family": "Nakano", "sequence": "additional", "affiliation": [{"name": "Department of Pathology, Medical School and Graduate School of Frontier Biosciences, Osaka University, Suita 565-0871, Japan"}]}], "member": "288", "published-online": {"date-parts": [[2007, 3, 20]]}, "reference": [{"key": "2019102704292829100_B1", "author": "Li", "volume": "275", "first-page": "1943", "year": "1997", "journal-title": "Science", "DOI": "10.1126/science.275.5308.1943", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B2", "author": "Liaw", "volume": "16", "first-page": "64", "year": "1997", "journal-title": "Nat. Genet.", "DOI": "10.1038/ng0597-64", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B3", "author": "Marsh", "volume": "16", "first-page": "333", "year": "1997", "journal-title": "Nat. Genet.", "DOI": "10.1038/ng0897-333", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B4", "author": "Myers", "volume": "95", "first-page": "13513", "year": "1998", "journal-title": "Proc. Natl. Acad. Sci. U.S.A.", "DOI": "10.1073/pnas.95.23.13513", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B5", "author": "Maehama", "volume": "273", "first-page": "13375", "year": "1998", "journal-title": "J. Biol. Chem.", "DOI": "10.1074/jbc.273.22.13375", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B6", "author": "Toker", "volume": "387", "first-page": "673", "year": "1997", "journal-title": "Nature", "DOI": "10.1038/42648", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B7", "author": "Stoyanov", "volume": "269", "first-page": "690", "year": "1995", "journal-title": "Science", "DOI": "10.1126/science.7624799", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B8", "author": "Stephens", "volume": "89", "first-page": "105", "year": "1997", "journal-title": "Cell", "DOI": "10.1016/S0092-8674(00)80187-7", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B9", "author": "Suzuki", "volume": "8", "first-page": "1169", "year": "1998", "journal-title": "Curr. Biol.", "DOI": "10.1016/S0960-9822(07)00488-5", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B10", "author": "Di\u00a0Cristofano", "volume": "19", "first-page": "348", "year": "1998", "journal-title": "Nat. Genet.", "DOI": "10.1038/1235", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B11", "author": "Podsypanina", "volume": "96", "first-page": "1563", "year": "1999", "journal-title": "Proc. Natl. Acad. Sci. U.S.A.", "DOI": "10.1073/pnas.96.4.1563", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B12", "author": "Stambolic", "volume": "95", "first-page": "29", "year": "1998", "journal-title": "Cell", "DOI": "10.1016/S0092-8674(00)81780-8", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B13", "author": "Stambolic", "volume": "60", "first-page": "3605", "year": "2000", "journal-title": "Cancer Res."}, {"key": "2019102704292829100_B14", "author": "Di\u00a0Cristofano", "volume": "285", "first-page": "2122", "year": "1999", "journal-title": "Science", "DOI": "10.1126/science.285.5436.2122", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B15", "author": "Suzuki", "volume": "14", "first-page": "523", "year": "2001", "journal-title": "Immunity", "DOI": "10.1016/S1074-7613(01)00134-0", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B16", "author": "Suzuki", "volume": "63", "first-page": "674", "year": "2003", "journal-title": "Cancer Res."}, {"key": "2019102704292829100_B17", "author": "Kimura", "volume": "130", "first-page": "1691", "year": "2003", "journal-title": "Development", "DOI": "10.1242/dev.00392", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B18", "author": "Horie", "volume": "113", "first-page": "1774", "year": "2004", "journal-title": "J. Clin. Invest.", "DOI": "10.1172/JCI20513", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B19", "author": "Li", "volume": "129", "first-page": "4159", "year": "2002", "journal-title": "Development"}, {"key": "2019102704292829100_B20", "author": "Stanger", "volume": "8", "first-page": "185", "year": "2005", "journal-title": "Cancer Cell", "DOI": "10.1016/j.ccr.2005.07.015", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B21", "author": "Backman", "volume": "101", "first-page": "1725", "year": "2004", "journal-title": "Proc. Natl. Acad. Sci. U.S.A.", "DOI": "10.1073/pnas.0308217100", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B22", "author": "Wang", "volume": "4", "first-page": "209", "year": "2003", "journal-title": "Cancer Cell", "DOI": "10.1016/S1535-6108(03)00215-0", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B23", "author": "Chen", "volume": "436", "first-page": "725", "year": "2005", "journal-title": "Nature", "DOI": "10.1038/nature03918", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B24", "author": "Tsuruta", "volume": "66", "first-page": "8389", "year": "2006", "journal-title": "Cancer Res.", "DOI": "10.1158/0008-5472.CAN-05-4627", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B25", "author": "Zhang", "volume": "441", "first-page": "518", "year": "2006", "journal-title": "Nature", "DOI": "10.1038/nature04747", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B26", "author": "Yilmaz", "volume": "441", "first-page": "475", "year": "2006", "journal-title": "Nature", "DOI": "10.1038/nature04703", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B27", "author": "Crackower", "volume": "110", "first-page": "737", "year": "2002", "journal-title": "Cell", "DOI": "10.1016/S0092-8674(02)00969-8", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B28", "author": "Daniel", "volume": "62", "first-page": "649", "year": "2000", "journal-title": "Annu. Rev. Physiol.", "DOI": "10.1146/annurev.physiol.62.1.649", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B29", "author": "Suri", "volume": "87", "first-page": "1171", "year": "1996", "journal-title": "Cell", "DOI": "10.1016/S0092-8674(00)81813-9", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B30", "author": "Lindahl", "volume": "277", "first-page": "242", "year": "1997", "journal-title": "Science", "DOI": "10.1126/science.277.5323.242", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B31", "author": "Lindblom", "volume": "17", "first-page": "1835", "year": "2003", "journal-title": "Genes Dev.", "DOI": "10.1101/gad.266803", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B32", "author": "Dickson", "volume": "121", "first-page": "1845", "year": "1995", "journal-title": "Development"}, {"key": "2019102704292829100_B33", "author": "Larsson", "volume": "20", "first-page": "1663", "year": "2001", "journal-title": "EMBO J.", "DOI": "10.1093/emboj/20.7.1663", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B34", "author": "Huang", "volume": "277", "first-page": "10760", "year": "2002", "journal-title": "J. Biol. Chem.", "DOI": "10.1074/jbc.M110219200", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B35", "author": "Su", "volume": "63", "first-page": "3585", "year": "2003", "journal-title": "Cancer Res."}, {"key": "2019102704292829100_B36", "author": "Hamada", "volume": "19", "first-page": "2054", "year": "2005", "journal-title": "Genes Dev.", "DOI": "10.1101/gad.1308805", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B37", "author": "Sun", "volume": "102", "first-page": "128", "year": "2005", "journal-title": "Proc. Natl. Acad. Sci. U.S.A.", "DOI": "10.1073/pnas.0403198102", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B38", "author": "Furuyama", "volume": "279", "first-page": "34741", "year": "2004", "journal-title": "J. Biol. Chem.", "DOI": "10.1074/jbc.M314214200", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B39", "author": "Wang", "volume": "93", "first-page": "741", "year": "1998", "journal-title": "Cell", "DOI": "10.1016/S0092-8674(00)81436-1", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B40", "author": "Dumont", "volume": "8", "first-page": "1897", "year": "1994", "journal-title": "Genes Dev.", "DOI": "10.1101/gad.8.16.1897", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B41", "author": "Hammes", "volume": "53", "first-page": "1104", "year": "2004", "journal-title": "Diabetes", "DOI": "10.2337/diabetes.53.4.1104", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B42", "author": "Zeng", "volume": "211", "first-page": "215", "year": "1998", "journal-title": "Dev. Dyn.", "DOI": "10.1002/(SICI)1097-0177(199803)211:3<215::AID-AJA3>3.0.CO;2-K", "doi-asserted-by": "crossref"}, {"key": "2019102704292829100_B43", "author": "Miquerol", "volume": "127", "first-page": "3941", "year": "2000", "journal-title": "Development"}, {"key": "2019102704292829100_B44", "author": "Kwee", "volume": "121", "first-page": "489", "year": "1995", "journal-title": "Development"}, {"key": "2019102704292829100_B45", "author": "Dimmeler", "volume": "83", "first-page": "334", "year": "1998", "journal-title": "Circ. Res.", "DOI": "10.1161/01.RES.83.3.334", "doi-asserted-by": "crossref"}], "container-title": ["Biochemical Society Transactions"], "language": "en", "link": [{"URL": "http://portlandpress.com/biochemsoctrans/article-pdf/35/2/172/542331/bst0350172.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://portlandpress.com/biochemsoctrans/article-pdf/35/2/172/542331/bst0350172.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 27]], "date-time": "2019-10-27T08:29:39Z", "timestamp": 1572164979000}, "score": 24.21544, "issued": {"date-parts": [[2007, 3, 20]]}, "references-count": 45, "journal-issue": {"published-online": {"date-parts": [[2007, 3, 20]]}, "published-print": {"date-parts": [[2007, 4, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1042/bst0350172", "relation": {"cites": []}, "ISSN": ["0300-5127", "1470-8752"], "issn-type": [{"value": "0300-5127", "type": "print"}, {"value": "1470-8752", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T11:09:16Z", "timestamp": 1575457756953}, "reference-count": 31, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 6, 1]], "date-time": "2014-06-01T00:00:00Z", "timestamp": 1401580800000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "Nantong City Applied Research Program", "award": ["BK2013007"]}, {"name": "Priority Academic Program Development of Jiangsu Higher Education Institutions", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience"], "published-print": {"date-parts": [[2014, 6]]}, "DOI": "10.1016/j.neuroscience.2014.03.039", "type": "journal-article", "created": {"date-parts": [[2014, 3, 27]], "date-time": "2014-03-27T17:18:56Z", "timestamp": 1395940736000}, "page": "93-101", "source": "Crossref", "is-referenced-by-count": 45, "title": ["The role of TLR4-mediated PTEN/PI3K/AKT/NF-\u03baB signaling pathway in neuroinflammation in hippocampal neurons"], "prefix": "10.1016", "volume": "269", "author": [{"given": "M.", "family": "Zhao", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Zhou", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Xu", "sequence": "additional", "affiliation": []}, {"given": "X.", "family": "Zhang", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0306452214002528?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0306452214002528?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 9]], "date-time": "2019-08-09T00:13:38Z", "timestamp": 1565309618000}, "score": 24.21544, "issued": {"date-parts": [[2014, 6]]}, "references-count": 31, "alternative-id": ["S0306452214002528"], "URL": "http://dx.doi.org/10.1016/j.neuroscience.2014.03.039", "ISSN": ["0306-4522"], "issn-type": [{"value": "0306-4522", "type": "print"}], "subject": ["General Neuroscience"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:40:09Z", "timestamp": 1574113209971}, "reference-count": 27, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2002, 3, 28]], "date-time": "2002-03-28T00:00:00Z", "timestamp": 1017273600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cell Death Differ"], "published-print": {"date-parts": [[2002, 4]]}, "DOI": "10.1038/sj.cdd.4400982", "type": "journal-article", "created": {"date-parts": [[2002, 9, 5]], "date-time": "2002-09-05T18:23:47Z", "timestamp": 1031250227000}, "page": "414-420", "source": "Crossref", "is-referenced-by-count": 22, "title": ["PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway"], "prefix": "10.1038", "volume": "9", "author": [{"given": "X", "family": "Wan", "sequence": "first", "affiliation": []}, {"given": "Y", "family": "Yokoyama", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Shinohara", "sequence": "additional", "affiliation": []}, {"given": "Y", "family": "Takahashi", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Tamaya", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2002, 3, 28]]}, "reference": [{"key": "BF4400982_CR1", "doi-asserted-by": "publisher", "first-page": "1943", "DOI": "10.1126/science.275.5308.1943", "volume": "275", "author": "J Li", "year": "1997", "unstructured": "Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R . 1997 PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275: 1943\u20131947", "journal-title": "Science"}, {"key": "BF4400982_CR2", "doi-asserted-by": "publisher", "first-page": "356", "DOI": "10.1038/ng0497-356", "volume": "15", "author": "PA Steck", "year": "1997", "unstructured": "Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV . 1997 Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat. Genet 15: 356\u2013362", "journal-title": "Nat. Genet"}, {"key": "BF4400982_CR3", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1016/S0092-8674(00)81780-8", "volume": "95", "author": "V Stambolic", "year": "1998", "unstructured": "Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW . 1998 Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95: 29\u201339", "journal-title": "Cell"}, {"key": "BF4400982_CR4", "first-page": "M21", "volume": "1470", "author": "F Vazquez", "year": "2000", "unstructured": "Vazquez F, Sellers WR . 2000 The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling Biochim. Biophys. Acta 1470: M21\u201335", "journal-title": "Biochim. Biophys. Acta"}, {"key": "BF4400982_CR5", "doi-asserted-by": "publisher", "first-page": "707", "DOI": "10.1126/science.279.5351.707", "volume": "279", "author": "N Pullen", "year": "1998", "unstructured": "Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G . 1998 Phosphorylation and activation of p70s6k by PDK1 Science 279: 707\u2013710", "journal-title": "Science"}, {"key": "BF4400982_CR6", "doi-asserted-by": "publisher", "first-page": "20806", "DOI": "10.1074/jbc.M000421200", "volume": "275", "author": "A Balendran", "year": "2000", "unstructured": "Balendran A, Biondi RM, Cheung PC, Casamayor A, Deak M, Alessi DR . 2000 A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Czeta (PKCzeta) and PKC-related kinase 2 by PDK1 J. Biol. Chem 275: 20806\u201320813", "journal-title": "J. Biol. Chem"}, {"key": "BF4400982_CR7", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1016/S0014-5793(00)02162-1", "volume": "484", "author": "A Balendran", "year": "2000", "unstructured": "Balendran A, Hare GR, Kieloch A, Williams MR, Alessi DR . 2000 Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms FEBS. Lett 484: 217\u2013223", "journal-title": "FEBS. Lett"}, {"key": "BF4400982_CR8", "doi-asserted-by": "publisher", "first-page": "34", "DOI": "10.1006/excr.2000.4836", "volume": "256", "author": "TG Cross", "year": "2000", "unstructured": "Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM . 2000 Serine/threonine protein kinases and apoptosis Exp. Cell Res 256: 34\u201341", "journal-title": "Exp. Cell Res"}, {"key": "BF4400982_CR9", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1016/0304-3835(96)04346-7", "volume": "107", "author": "L Qiao", "year": "1996", "unstructured": "Qiao L, Koutsos M, Tsai LL, Kozoni V, Guzman J, Shiff SJ, Rigas B . 1996 Staurosporine inhibits the proliferation, alters the cell cycle distribution and induces apoptosis in HT-29 human colon adenocarcinoma cells Cancer Lett 107: 83\u201389", "journal-title": "Cancer Lett"}, {"key": "BF4400982_CR10", "doi-asserted-by": "publisher", "first-page": "415", "DOI": "10.1159/000239600", "volume": "43", "author": "D Kobayashi", "year": "1997", "unstructured": "Kobayashi D, Watanabe N, Yamauchi N, Tsuji N, Sato T, Sasaki H, Okamoto T, Niitsu Y . 1997 Protein kinase C inhibitors augment tumor-necrosis-factor-induced apoptosis in normal human diploid cells Chemotherapy 43: 415\u2013423", "journal-title": "Chemotherapy"}, {"key": "BF4400982_CR11", "first-page": "663", "volume": "54", "author": "ST Harkin", "year": "1998", "unstructured": "Harkin ST, Cohen GM, Gescher A . 1998 Modulation of apoptosis in rat thymocytes by analogs of staurosporine: lack of direct association with inhibition of protein kinase C Mol. Pharmacol 54: 663\u2013670", "journal-title": "Mol. Pharmacol"}, {"key": "BF4400982_CR12", "doi-asserted-by": "publisher", "first-page": "5010", "DOI": "10.1128/MCB.20.14.5010-5018.2000", "volume": "20", "author": "F Vazquez", "year": "2000", "unstructured": "Vazquez F, Ramaswamy S, Nakamura N, Sellers WR . 2000 Phosphorylation of the PTEN tail regulates protein stability and function Mol. Cell Biol 20: 5010\u20135018", "journal-title": "Mol. Cell Biol"}, {"key": "BF4400982_CR13", "first-page": "5808", "volume": "59", "author": "LP Weng", "year": "1999", "unstructured": "Weng LP, Smith WM, Dahia PL, Ziebold U, Gil E, Lees JA, Eng C . 1999 PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death Cancer Res 59: 5808\u20135814", "journal-title": "Cancer Res"}, {"key": "BF4400982_CR14", "doi-asserted-by": "publisher", "first-page": "822", "DOI": "10.3171/jns.1999.91.5.0822", "volume": "91", "author": "J Adachi", "year": "1999", "unstructured": "Adachi J, Ohbayashi K, Suzuki T, Sasaki T . 1999 Cell cycle arrest and astrocytic differentiation resulting from PTEN expression in glioma cells J. Neurosurg 91: 822\u2013830", "journal-title": "J. Neurosurg"}, {"key": "BF4400982_CR15", "first-page": "2318", "volume": "59", "author": "IW Cheney", "year": "1999", "unstructured": "Cheney IW, Neuteboom ST, Vaillancourt MT, Ramachandra M, Bookstein R . 1999 Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes Cancer Res 59: 2318\u20132323", "journal-title": "Cancer Res"}, {"key": "BF4400982_CR16", "first-page": "2105", "volume": "61", "author": "AR Gottschalk", "year": "2001", "unstructured": "Gottschalk AR, Basila D, Wong M, Dean NM, Brandts CH, Stokoe D, Haas-Kogan DA . 2001 p27Kip1 is required for PTEN-induced G1 growth arrest Cancer Res 61: 2105\u20132111", "journal-title": "Cancer Res"}, {"key": "BF4400982_CR17", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.1016/0006-291X(86)90008-2", "volume": "135", "author": "T Tamaoki", "year": "1986", "unstructured": "Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F . 1986 Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase Biochem. Biophys. Res. Commun 135: 397\u2013402", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "BF4400982_CR18", "doi-asserted-by": "publisher", "first-page": "721", "DOI": "10.1016/S0306-3623(98)00069-X", "volume": "31", "author": "A Gescher", "year": "1998", "unstructured": "Gescher A . 1998 Analogs of staurosporine: potential anticancer drugs? Gen. Pharmacol 31: 721\u2013728", "journal-title": "Gen. Pharmacol"}, {"key": "BF4400982_CR19", "doi-asserted-by": "publisher", "first-page": "564", "DOI": "10.7164/antibiotics.42.564", "volume": "42", "author": "I Takahashi", "year": "1989", "unstructured": "Takahashi I, Asano K, Kawamoto I, Tamaoki T, Nakano H . 1989 UCN-01 and UCN-02, new selective inhibitors of protein kinase C. I. Screening, producing organism and fermentation J. Antibiot 42: 564\u2013570", "journal-title": "J. Antibiot"}, {"key": "BF4400982_CR20", "doi-asserted-by": "publisher", "first-page": "1364", "DOI": "10.1111/j.1349-7006.1999.tb00721.x", "volume": "90", "author": "T Akiyama", "year": "1999", "unstructured": "Akiyama T, Sugiyama K, Shimizu M, Tamaoki T, Akinaga S . 1999 G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation Jpn. J. Cancer Res 90: 1364\u20131372", "journal-title": "Jpn. J. Cancer Res"}, {"key": "BF4400982_CR21", "first-page": "4406", "volume": "59", "author": "K Sugiyama", "year": "1999", "unstructured": "Sugiyama K, Akiyama T, Shimizu M, Tamaoki T, Courage C, Gescher A, Akinaga S . 1999 Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine) Cancer Res 59: 4406\u20134412", "journal-title": "Cancer Res"}, {"key": "BF4400982_CR22", "doi-asserted-by": "publisher", "first-page": "5600", "DOI": "10.1074/jbc.275.8.5600", "volume": "275", "author": "PR Graves", "year": "2000", "unstructured": "Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM, Piwnica-Worms H . 2000 The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01 J. Biol Chem 275: 5600\u20135605", "journal-title": "J. Biol Chem"}, {"key": "BF4400982_CR23", "first-page": "2108", "volume": "60", "author": "EC Busby", "year": "2000", "unstructured": "Busby EC, Leistritz DF, Abraham RT, Karnitz LM, Sarkaria JN . 2000 The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1 Cancer Res 60: 2108\u20132112", "journal-title": "Cancer Res"}, {"key": "BF4400982_CR24", "doi-asserted-by": "publisher", "first-page": "340", "DOI": "10.1016/0076-6879(91)01030-6", "volume": "201", "author": "T Tamaoki", "year": "1991", "unstructured": "Tamaoki T . 1991 Use and specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors Methods Enzymol 201: 340\u2013347", "journal-title": "Methods Enzymol"}, {"key": "BF4400982_CR25", "first-page": "5988", "volume": "60", "author": "J Hayakawa", "year": "2000", "unstructured": "Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T, Murata Y . 2000 Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin Cancer Res 60: 5988\u20135994", "journal-title": "Cancer Res"}, {"key": "BF4400982_CR26", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1074/jbc.M002650200", "volume": "276", "author": "D Maiti", "year": "2001", "unstructured": "Maiti D, Bhattacharyya A, Basu J . 2001 Lipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating Bad through a phosphatidylinisitol 3-kinase/Akt pathway J. Biol. Chem 276: 329\u2013333", "journal-title": "J. Biol. Chem"}, {"key": "BF4400982_CR27", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1006/gyno.1998.5039", "volume": "70", "author": "GL Maxwell", "year": "1998", "unstructured": "Maxwell GL, Risinger JI, Tong B, Shaw H, Barrett JC, Berchuck A, Futreal PA . 1998 Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers Gynecol. Oncol 70: 13\u201316", "journal-title": "Gynecol. Oncol"}], "container-title": ["Cell Death & Differentiation"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/4400982.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4400982", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4400982.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T10:50:28Z", "timestamp": 1552819828000}, "score": 23.016523, "issued": {"date-parts": [[2002, 3, 28]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2002, 4]]}, "issue": "4"}, "alternative-id": ["BF4400982"], "URL": "http://dx.doi.org/10.1038/sj.cdd.4400982", "relation": {"cites": []}, "ISSN": ["1350-9047", "1476-5403"], "issn-type": [{"value": "1350-9047", "type": "print"}, {"value": "1476-5403", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:44:12Z", "timestamp": 1574491452250}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Research"], "published-print": {"date-parts": [[2011, 2, 1]]}, "DOI": "10.1158/0008-5472.can-10-2488", "type": "journal-article", "created": {"date-parts": [[2011, 1, 26]], "date-time": "2011-01-26T01:16:07Z", "timestamp": 1296004567000}, "page": "629-633", "source": "Crossref", "is-referenced-by-count": 137, "title": ["PTEN Level in Tumor Suppression: How Much Is Too Little?"], "prefix": "10.1158", "volume": "71", "author": [{"given": "A.", "family": "Carracedo", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Alimonti", "sequence": "additional", "affiliation": []}, {"given": "P. P.", "family": "Pandolfi", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2011, 1, 25]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-10-2488", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T14:12:50Z", "timestamp": 1482502370000}, "score": 22.894241, "issued": {"date-parts": [[2011, 1, 25]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2011, 2, 1]]}, "published-print": {"date-parts": [[2011, 2, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1158/0008-5472.can-10-2488", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:58:56Z", "timestamp": 1574139536149}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 11, 1]]}, "DOI": "10.1093/ndt/17.11.1971", "type": "journal-article", "created": {"date-parts": [[2002, 10, 26]], "date-time": "2002-10-26T00:02:49Z", "timestamp": 1035590569000}, "page": "1971-1977", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Caspase-3-dependent pathway mediates apoptosis of human mononuclear cells induced by cellulosic haemodialysis membranes"], "prefix": "10.1093", "volume": "17", "author": [{"given": "J.", "family": "Carracedo", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["Nephrology Dialysis Transplantation"], "link": [{"URL": "http://academic.oup.com/ndt/article-pdf/17/11/1971/5357270/171971.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 24]], "date-time": "2017-08-24T08:00:22Z", "timestamp": 1503561622000}, "score": 21.801594, "issued": {"date-parts": [[2002, 11, 1]]}, "references-count": 0, "journal-issue": {"issue": "11"}, "URL": "http://dx.doi.org/10.1093/ndt/17.11.1971", "ISSN": ["1460-2385"], "issn-type": [{"value": "1460-2385", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T02:26:31Z", "timestamp": 1574821591896}, "reference-count": 0, "publisher": "Reactome", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Reactome"], "DOI": "10.3180/r-hsa-6807070.1", "type": "journal-article", "created": {"date-parts": [[2017, 8, 10]], "date-time": "2017-08-10T22:36:42Z", "timestamp": 1502404602000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["PTEN Regulation"], "prefix": "10.3180", "volume": "61", "author": [{"given": "A", "family": "Carracedo", "sequence": "first", "affiliation": []}, {"given": "L", "family": "Salmena", "sequence": "additional", "affiliation": []}, {"given": "N", "family": "Leslie", "sequence": "additional", "affiliation": []}, {"given": "N", "family": "Kriplani", "sequence": "additional", "affiliation": []}], "member": "1763", "published-online": {"date-parts": [[2017, 6, 12]]}, "container-title": ["Reactome - a curated knowledgebase of biological pathways"], "language": "en", "deposited": {"date-parts": [[2017, 8, 10]], "date-time": "2017-08-10T22:36:45Z", "timestamp": 1502404605000}, "score": 21.579056, "editor": [{"given": "M", "family": "Milacic", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[2017, 6, 12]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3180/r-hsa-6807070.1", "ISSN": ["1934-1792"], "issn-type": [{"value": "1934-1792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T20:17:31Z", "timestamp": 1574367451899}, "reference-count": 122, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 5, 1]], "date-time": "2008-05-01T00:00:00Z", "timestamp": 1209600000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2013, 7, 17]], "date-time": "2013-07-17T00:00:00Z", "timestamp": 1374019200000}, "delay-in-days": 1903, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cell"], "published-print": {"date-parts": [[2008, 5]]}, "DOI": "10.1016/j.cell.2008.04.013", "type": "journal-article", "created": {"date-parts": [[2008, 5, 4]], "date-time": "2008-05-04T07:05:51Z", "timestamp": 1209884751000}, "page": "403-414", "source": "Crossref", "is-referenced-by-count": 618, "title": ["Tenets of PTEN Tumor Suppression"], "prefix": "10.1016", "volume": "133", "author": [{"given": "Leonardo", "family": "Salmena", "sequence": "first", "affiliation": []}, {"given": "Arkaitz", "family": "Carracedo", "sequence": "additional", "affiliation": []}, {"given": "Pier Paolo", "family": "Pandolfi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cell"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0092867408005047?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0092867408005047?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 11]], "date-time": "2019-05-11T01:58:11Z", "timestamp": 1557539891000}, "score": 21.325087, "issued": {"date-parts": [[2008, 5]]}, "references-count": 122, "journal-issue": {"published-print": {"date-parts": [[2008, 5]]}, "issue": "3"}, "alternative-id": ["S0092867408005047"], "URL": "http://dx.doi.org/10.1016/j.cell.2008.04.013", "ISSN": ["0092-8674"], "issn-type": [{"value": "0092-8674", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T20:15:21Z", "timestamp": 1574367321100}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 5, 1]], "date-time": "2008-05-01T00:00:00Z", "timestamp": 1209600000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2013, 8, 17]], "date-time": "2013-08-17T00:00:00Z", "timestamp": 1376697600000}, "delay-in-days": 1934, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cell"], "published-print": {"date-parts": [[2008, 5]]}, "DOI": "10.1016/j.cell.2008.04.023", "type": "journal-article", "created": {"date-parts": [[2008, 5, 4]], "date-time": "2008-05-04T05:09:38Z", "timestamp": 1209877778000}, "page": "550-550.e1", "source": "Crossref", "is-referenced-by-count": 9, "title": ["SnapShot: PTEN Signaling Pathways"], "prefix": "10.1016", "volume": "133", "author": [{"given": "Arkaitz", "family": "Carracedo", "sequence": "first", "affiliation": []}, {"given": "Leonardo", "family": "Salmena", "sequence": "additional", "affiliation": []}, {"given": "Pier Paolo", "family": "Pandolfi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cell"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0092867408005151?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0092867408005151?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 29]], "date-time": "2018-12-29T07:22:29Z", "timestamp": 1546068149000}, "score": 21.325087, "issued": {"date-parts": [[2008, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 5]]}, "issue": "3"}, "alternative-id": ["S0092867408005151"], "URL": "http://dx.doi.org/10.1016/j.cell.2008.04.023", "ISSN": ["0092-8674"], "issn-type": [{"value": "0092-8674", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T01:40:55Z", "timestamp": 1574732455020}, "reference-count": 166, "publisher": "Portland Press Ltd.", "issue": "3", "content-domain": {"domain": ["portlandpress.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2017, 2, 1]]}, "abstract": "<jats:p>Loss of function of the PTEN tumour suppressor, resulting in dysregulated activation of the phosphoinositide 3-kinase (PI3K) signalling network, is recognized as one of the most common driving events in prostate cancer development. The observed mechanisms of PTEN loss are diverse, but both homozygous and heterozygous genomic deletions including PTEN are frequent, and often accompanied by loss of detectable protein as assessed by immunohistochemistry (IHC). The occurrence of PTEN loss is highest in aggressive metastatic disease and this has driven the development of PTEN as a prognostic biomarker, either alone or in combination with other factors, to distinguish indolent tumours from those likely to progress. Here, we discuss these factors and the consequences of PTEN loss, in the context of its role as a lipid phosphatase, as well as current efforts to use available inhibitors of specific components of the PI3K/PTEN/TOR signalling network in prostate cancer treatment.</jats:p>", "DOI": "10.1042/cs20160026", "type": "journal-article", "created": {"date-parts": [[2017, 1, 6]], "date-time": "2017-01-06T01:50:19Z", "timestamp": 1483667419000}, "page": "197-210", "update-policy": "http://dx.doi.org/10.1042/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 37, "title": ["Prostate cancer, PI3K, PTEN and prognosis"], "prefix": "10.1042", "volume": "131", "author": [{"given": "Helen\u00a0M.", "family": "Wise", "sequence": "first", "affiliation": [{"name": "Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot Watt University, Edinburgh EH14 4AS, U.K."}]}, {"given": "Miguel\u00a0A.", "family": "Hermida", "sequence": "additional", "affiliation": [{"name": "Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot Watt University, Edinburgh EH14 4AS, U.K."}]}, {"given": "Nicholas\u00a0R.", "family": "Leslie", "sequence": "additional", "affiliation": [{"name": "Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot Watt University, Edinburgh EH14 4AS, U.K."}]}], "member": "288", "published-online": {"date-parts": [[2017, 1, 5]]}, "reference": [{"key": "2019102518152900300_B1", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1016/j.ccr.2010.05.026", "article-title": "Integrative genomic profiling of human prostate cancer", "volume": "18", "author": "Taylor", "year": "2010", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B2", "doi-asserted-by": "publisher", "first-page": "5497", "DOI": "10.1038/onc.2008.245", "article-title": "PI3K pathway alterations in cancer: variations on a theme", "volume": "27", "author": "Yuan", "year": "2008", "journal-title": "Oncogene"}, {"key": "2019102518152900300_B3", "doi-asserted-by": "publisher", "first-page": "195", "DOI": "10.1038/nrm3290", "article-title": "PI3K signalling: the path to discovery and understanding", "volume": "13", "author": "Vanhaesebroeck", "year": "2012", "journal-title": "Nat. Rev. Mol. Cell Biol."}, {"key": "2019102518152900300_B4", "doi-asserted-by": "publisher", "first-page": "627", "DOI": "10.1038/nrd2926", "article-title": "Targeting the phosphoinositide 3-kinase pathway in cancer", "volume": "8", "author": "Liu", "year": "2009", "journal-title": "Nat. Rev. Drug Discov."}, {"key": "2019102518152900300_B5", "doi-asserted-by": "publisher", "first-page": "554", "DOI": "10.1126/science.1096502", "article-title": "High frequency of mutations of the PIK3CA gene in human cancers", "volume": "304", "author": "Samuels", "year": "2004", "journal-title": "Science"}, {"key": "2019102518152900300_B6", "doi-asserted-by": "crossref", "first-page": "53.e15", "DOI": "10.1016/j.urolonc.2013.08.025", "article-title": "The prostate cancer genome: perspectives and potential", "volume": "32", "author": "Barbieri", "year": "2014", "journal-title": "Urologic Oncol."}, {"key": "2019102518152900300_B7", "doi-asserted-by": "publisher", "first-page": "1050", "DOI": "10.1016/j.cell.2013.04.031", "article-title": "RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms", "volume": "153", "author": "Fritsch", "year": "2013", "journal-title": "Cell"}, {"key": "2019102518152900300_B8", "doi-asserted-by": "crossref", "first-page": "776", "DOI": "10.1038/nature07091", "article-title": "Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis", "volume": "454", "author": "Jia", "year": "2008", "journal-title": "Nature"}, {"key": "2019102518152900300_B9", "doi-asserted-by": "publisher", "first-page": "13057", "DOI": "10.1073/pnas.0802655105", "article-title": "PTEN-deficient cancers depend on PIK3CB", "volume": "105", "author": "Wee", "year": "2008", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "2019102518152900300_B10", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1042/BJ20080639", "article-title": "A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition", "volume": "415", "author": "Torbett", "year": "2008", "journal-title": "Biochem. J."}, {"key": "2019102518152900300_B11", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1042/BJ20111741", "article-title": "Both p110alpha and p110beta isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor", "volume": "442", "author": "Berenjeno", "year": "2012", "journal-title": "Biochem. J."}, {"key": "2019102518152900300_B12", "doi-asserted-by": "publisher", "first-page": "6395", "DOI": "10.1073/pnas.1323004111", "article-title": "PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context", "volume": "111", "author": "Schmit", "year": "2014", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "2019102518152900300_B13", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1016/j.ccell.2014.11.007", "article-title": "Measurement of PIP3 levels reveals an unexpected role for p110beta in early adaptive responses to p110alpha-specific inhibitors in luminal breast cancer", "volume": "27", "author": "Costa", "year": "2015", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B14", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1016/j.ccell.2014.11.008", "article-title": "Feedback suppression of PI3Kalpha signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kbeta", "volume": "27", "author": "Schwartz", "year": "2015", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B15", "doi-asserted-by": "publisher", "first-page": "214", "DOI": "10.1038/nature09744", "article-title": "The genomic complexity of primary human prostate cancer", "volume": "470", "author": "Berger", "year": "2011", "journal-title": "Nature"}, {"key": "2019102518152900300_B16", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1038/nature11125", "article-title": "The mutational landscape of lethal castration-resistant prostate cancer", "volume": "487", "author": "Grasso", "year": "2012", "journal-title": "Nature"}, {"key": "2019102518152900300_B17", "doi-asserted-by": "publisher", "first-page": "1215", "DOI": "10.1016/j.cell.2015.05.001", "article-title": "Integrative clinical genomics of advanced prostate cancer", "volume": "161", "author": "Robinson", "year": "2015", "journal-title": "Cell"}, {"key": "2019102518152900300_B18", "doi-asserted-by": "publisher", "first-page": "578", "DOI": "10.1016/j.celrep.2013.12.038", "article-title": "Specificity and commonality of the phosphoinositide-binding proteome analyzed by quantitative mass spectrometry", "volume": "6", "author": "Jungmichel", "year": "2014", "journal-title": "Cell Rep."}, {"key": "2019102518152900300_B19", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1016/j.advenzreg.2011.09.010", "article-title": "Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases", "volume": "52", "author": "Leslie", "year": "2012", "journal-title": "Adv. Biol. Regul."}, {"key": "2019102518152900300_B20", "doi-asserted-by": "publisher", "first-page": "381", "DOI": "10.1016/j.molcel.2008.04.008", "article-title": "Comprehensive identification of PIP3-regulated PH domains from C. elegans to H. sapiens by model prediction and live imaging", "volume": "30", "author": "Park", "year": "2008", "journal-title": "Mol. Cell"}, {"key": "2019102518152900300_B21", "doi-asserted-by": "publisher", "first-page": "1569", "DOI": "10.1101/gad.1395006", "article-title": "The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice", "volume": "20", "author": "Chen", "year": "2006", "journal-title": "Genes Dev."}, {"key": "2019102518152900300_B22", "doi-asserted-by": "publisher", "first-page": "887", "DOI": "10.1016/S1097-2765(00)80303-2", "article-title": "The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway", "volume": "2", "author": "Ogg", "year": "1998", "journal-title": "Mol. Cell"}, {"key": "2019102518152900300_B23", "doi-asserted-by": "publisher", "first-page": "2488", "DOI": "10.1101/gad.12.16.2488", "article-title": "Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor", "volume": "12", "author": "Paradis", "year": "1998", "journal-title": "Genes Dev."}, {"key": "2019102518152900300_B24", "doi-asserted-by": "publisher", "first-page": "2088", "DOI": "10.1126/science.1068094", "article-title": "Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB", "volume": "295", "author": "Stocker", "year": "2002", "journal-title": "Science"}, {"key": "2019102518152900300_B25", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1016/j.jbior.2014.04.001", "article-title": "Signaling specificity in the Akt pathway in biology and disease", "volume": "55", "author": "Toker", "year": "2014", "journal-title": "Adv. Biol. Regul."}, {"key": "2019102518152900300_B26", "doi-asserted-by": "publisher", "first-page": "1261", "DOI": "10.1016/j.cell.2007.06.009", "article-title": "AKT/PKB signaling: navigating downstream", "volume": "129", "author": "Manning", "year": "2007", "journal-title": "Cell"}, {"key": "2019102518152900300_B27", "doi-asserted-by": "publisher", "first-page": "545", "DOI": "10.1016/j.tcb.2015.06.002", "article-title": "Regulation of mTORC1 by PI3K signaling", "volume": "25", "author": "Dibble", "year": "2015", "journal-title": "Trends Cell Biol."}, {"key": "2019102518152900300_B28", "doi-asserted-by": "publisher", "first-page": "951", "DOI": "10.1242/jcs.02801", "article-title": "PTEN couples Sema3A signalling to growth cone collapse", "volume": "119", "author": "Chadborn", "year": "2006", "journal-title": "J. Cell Sci."}, {"key": "2019102518152900300_B29", "doi-asserted-by": "publisher", "first-page": "5464", "DOI": "10.1038/onc.2008.243", "article-title": "Understanding PTEN regulation: PIP2, polarity and protein stability", "volume": "27", "author": "Leslie", "year": "2008", "journal-title": "Oncogene"}, {"key": "2019102518152900300_B30", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1016/S0092-8674(00)81784-5", "article-title": "G protein signaling events are activated at the leading edge of chemotactic cells", "volume": "95", "author": "Parent", "year": "1998", "journal-title": "Cell"}, {"key": "2019102518152900300_B31", "doi-asserted-by": "publisher", "first-page": "1037", "DOI": "10.1126/science.287.5455.1037", "article-title": "Polarization of chemoattractant receptor signaling during neutrophil chemotaxis", "volume": "287", "author": "Servant", "year": "2000", "journal-title": "Science"}, {"key": "2019102518152900300_B32", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.1016/S0960-9822(99)80192-4", "article-title": "Akt/PKB localisation and 3' phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction", "volume": "9", "author": "Watton", "year": "1999", "journal-title": "Curr. Biol."}, {"key": "2019102518152900300_B33", "doi-asserted-by": "publisher", "first-page": "ra4", "DOI": "10.1126/scisignal.2000014", "article-title": "EGFR signals to mTOR through PKC and independently of Akt in glioma", "volume": "2", "author": "Fan", "year": "2009", "journal-title": "Sci. Signal."}, {"key": "2019102518152900300_B34", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1016/j.ccr.2009.04.012", "article-title": "AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer", "volume": "16", "author": "Vasudevan", "year": "2009", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B35", "doi-asserted-by": "publisher", "first-page": "555", "DOI": "10.1016/j.ccr.2007.04.021", "article-title": "Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN", "volume": "11", "author": "Vivanco", "year": "2007", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B36", "doi-asserted-by": "publisher", "first-page": "4417", "DOI": "10.1038/onc.2012.459", "article-title": "Disruption of epithelial architecture caused by loss of PTEN or by oncogenic mutant p110alpha/PIK3CA but not by HER2 or mutant AKT1", "volume": "32", "author": "Berglund", "year": "2013", "journal-title": "Oncogene"}, {"key": "2019102518152900300_B37", "doi-asserted-by": "publisher", "first-page": "ra18", "DOI": "10.1126/scisignal.2002138", "article-title": "PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity", "volume": "5", "author": "Tibarewal", "year": "2012", "journal-title": "Sci. Signal."}, {"key": "2019102518152900300_B38", "doi-asserted-by": "publisher", "first-page": "2337", "DOI": "10.1038/onc.2009.516", "article-title": "Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations", "volume": "29", "author": "Lauring", "year": "2010", "journal-title": "Oncogene"}, {"key": "2019102518152900300_B39", "doi-asserted-by": "publisher", "first-page": "17301", "DOI": "10.18632/oncotarget.8191", "article-title": "Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis", "volume": "7", "author": "Mancini", "year": "2016", "journal-title": "Oncotarget"}, {"key": "2019102518152900300_B40", "doi-asserted-by": "publisher", "first-page": "240", "DOI": "10.1042/BST20150214", "article-title": "Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases", "volume": "44", "author": "Eramo", "year": "2016", "journal-title": "Biochem. Soc. Trans."}, {"key": "2019102518152900300_B41", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/j.ccr.2009.06.006", "article-title": "Evidence that inositol polyphosphate 4-phosphatase type\u00a0II is a tumor suppressor that inhibits PI3K signaling", "volume": "16", "author": "Gewinner", "year": "2009", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B42", "doi-asserted-by": "publisher", "first-page": "530", "DOI": "10.1016/j.molmed.2015.06.006", "article-title": "Phosphoinositide signaling in cancer: INPP4B Akt(s) out", "volume": "21", "author": "Woolley", "year": "2015", "journal-title": "Trends Mol. Med."}, {"key": "2019102518152900300_B43", "doi-asserted-by": "publisher", "first-page": "1061", "DOI": "10.1038/nature07385", "article-title": "Comprehensive genomic characterization defines human glioblastoma genes and core pathways", "volume": "455", "author": "Cancer Genome Atlas Research Network", "year": "2008", "journal-title": "Nature"}, {"key": "2019102518152900300_B44", "doi-asserted-by": "publisher", "first-page": "719", "DOI": "10.1038/nature07943", "article-title": "The cancer genome", "volume": "458", "author": "Stratton", "year": "2009", "journal-title": "Nature"}, {"key": "2019102518152900300_B45", "first-page": "4800", "article-title": "Loss of the chromosomal region 10q23-25\u00a0in prostate cancer", "volume": "55", "author": "Gray", "year": "1995", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B46", "first-page": "3111", "article-title": "Loss of heterozygosity for 10q22-10qter in malignant melanoma progression", "volume": "54", "author": "Herbst", "year": "1994", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B47", "first-page": "5817", "article-title": "Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma", "volume": "51", "author": "Morita", "year": "1991", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B48", "first-page": "1922", "article-title": "Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers", "volume": "55", "author": "Peiffer", "year": "1995", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B49", "doi-asserted-by": "publisher", "first-page": "1943", "DOI": "10.1126/science.275.5308.1943", "article-title": "PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer", "volume": "275", "author": "Li", "year": "1997", "journal-title": "Science"}, {"key": "2019102518152900300_B50", "doi-asserted-by": "publisher", "first-page": "356", "DOI": "10.1038/ng0497-356", "article-title": "Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers", "volume": "15", "author": "Steck", "year": "1997", "journal-title": "Nat. Genet."}, {"key": "2019102518152900300_B51", "doi-asserted-by": "publisher", "first-page": "64", "DOI": "10.1038/ng0597-64", "article-title": "Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome", "volume": "16", "author": "Liaw", "year": "1997", "journal-title": "Nat. Genet."}, {"key": "2019102518152900300_B52", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1038/ng0897-333", "article-title": "Germline mutations in PTEN are present in Bannayan-Zonana syndrome", "volume": "16", "author": "Marsh", "year": "1997", "journal-title": "Nat. Genet."}, {"key": "2019102518152900300_B53", "doi-asserted-by": "publisher", "first-page": "224", "DOI": "10.1016/j.cancergen.2010.12.011", "article-title": "Prostate cancer in Cowden syndrome: somatic loss and germline mutation of the PTEN gene", "volume": "204", "author": "Barbosa", "year": "2011", "journal-title": "Cancer Genet."}, {"key": "2019102518152900300_B54", "first-page": "2124", "article-title": "TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta", "volume": "57", "author": "Li", "year": "1997", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B55", "doi-asserted-by": "publisher", "first-page": "9052", "DOI": "10.1073/pnas.94.17.9052", "article-title": "P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase", "volume": "94", "author": "Myers", "year": "1997", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "2019102518152900300_B56", "doi-asserted-by": "publisher", "first-page": "13375", "DOI": "10.1074/jbc.273.22.13375", "article-title": "The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate", "volume": "273", "author": "Maehama", "year": "1998", "journal-title": "J. Biol. Chem."}, {"key": "2019102518152900300_B57", "doi-asserted-by": "publisher", "first-page": "13513", "DOI": "10.1073/pnas.95.23.13513", "article-title": "The lipid phosphatase activity of PTEN is critical for its tumor supressor function", "volume": "95", "author": "Myers", "year": "1998", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "2019102518152900300_B58", "first-page": "5002", "article-title": "The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells", "volume": "58", "author": "Furnari", "year": "1998", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B59", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1038/nrm3330", "article-title": "The functions and regulation of the PTEN tumour suppressor", "volume": "13", "author": "Song", "year": "2012", "journal-title": "Nat. Rev. Mol. Cell Biol."}, {"key": "2019102518152900300_B60", "doi-asserted-by": "publisher", "first-page": "641", "DOI": "10.1146/annurev-biochem-082411-113907", "article-title": "Pten", "volume": "83", "author": "Worby", "year": "2014", "journal-title": "Annu. Rev. Biochem."}, {"key": "2019102518152900300_B61", "doi-asserted-by": "publisher", "first-page": "595", "DOI": "10.1016/j.cell.2014.03.027", "article-title": "Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function", "volume": "157", "author": "Papa", "year": "2014", "journal-title": "Cell"}, {"key": "2019102518152900300_B62", "doi-asserted-by": "publisher", "first-page": "5142", "DOI": "10.1073/pnas.0912524107", "article-title": "Allele-specific tumor spectrum in pten knockin mice", "volume": "107", "author": "Wang", "year": "2010", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "2019102518152900300_B63", "doi-asserted-by": "publisher", "first-page": "3633", "DOI": "10.1073/pnas.0510570103", "article-title": "Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane", "volume": "103", "author": "Vazquez", "year": "2006", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "2019102518152900300_B64", "doi-asserted-by": "publisher", "first-page": "5160", "DOI": "10.1242/jcs.000133", "article-title": "Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression", "volume": "119", "author": "Lindsay", "year": "2006", "journal-title": "J. Cell Sci."}, {"key": "2019102518152900300_B65", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1016/j.molcel.2015.03.011", "article-title": "PTEN functions by recruitment to cytoplasmic vesicles", "volume": "58", "author": "Naguib", "year": "2015", "journal-title": "Mol. Cell"}, {"key": "2019102518152900300_B66", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1038/nn.4225", "article-title": "PTEN recruitment controls synaptic and cognitive function in Alzheimer's models", "volume": "19", "author": "Knafo", "year": "2016", "journal-title": "Nat. Neurosci."}, {"key": "2019102518152900300_B67", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/j.cub.2006.12.026", "article-title": "PtdIns(3,4,5)P3-dependent and -independent roles for PTEN in the control of cell migration", "volume": "17", "author": "Leslie", "year": "2007", "journal-title": "Curr. Biol."}, {"key": "2019102518152900300_B68", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1016/j.cell.2006.11.051", "article-title": "PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42", "volume": "128", "author": "Martin-Belmonte", "year": "2007", "journal-title": "Cell"}, {"key": "2019102518152900300_B69", "doi-asserted-by": "publisher", "first-page": "886", "DOI": "10.1016/j.molcel.2007.10.028", "article-title": "PDZ domains of Par-3 as potential phosphoinositide signaling integrators", "volume": "28", "author": "Wu", "year": "2007", "journal-title": "Mol. Cell"}, {"key": "2019102518152900300_B70", "doi-asserted-by": "publisher", "first-page": "3147", "DOI": "10.1101/gad.1700108", "article-title": "Retinal degeneration triggered by inactivation of PTEN in the retinal pigment epithelium", "volume": "22", "author": "Kim", "year": "2008", "journal-title": "Genes Dev."}, {"key": "2019102518152900300_B71", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1038/modpathol.2014.85", "article-title": "PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy", "volume": "28", "author": "Lotan", "year": "2015", "journal-title": "Mod. Pathol."}, {"key": "2019102518152900300_B72", "doi-asserted-by": "publisher", "first-page": "6492", "DOI": "10.1158/0008-5472.CAN-05-4143", "article-title": "Genetic background controls tumor development in PTEN-deficient mice", "volume": "66", "author": "Freeman", "year": "2006", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B73", "first-page": "3605", "article-title": "High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice", "volume": "60", "author": "Stambolic", "year": "2000", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B74", "doi-asserted-by": "publisher", "first-page": "E59", "DOI": "10.1371/journal.pbio.0000059", "article-title": "Pten dose dictates cancer progression in the prostate", "volume": "1", "author": "Trotman", "year": "2003", "journal-title": "PLoS Biol."}, {"key": "2019102518152900300_B75", "doi-asserted-by": "publisher", "first-page": "454", "DOI": "10.1038/ng.556", "article-title": "Subtle variations in Pten dose determine cancer susceptibility", "volume": "42", "author": "Alimonti", "year": "2010", "journal-title": "Nat. Genet."}, {"key": "2019102518152900300_B76", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1016/j.cell.2012.02.030", "article-title": "Systemic elevation of PTEN induces a tumor-suppressive metabolic state", "volume": "149", "author": "Garcia-Cao", "year": "2012", "journal-title": "Cell"}, {"key": "2019102518152900300_B77", "doi-asserted-by": "publisher", "first-page": "382", "DOI": "10.1016/j.cmet.2012.02.001", "article-title": "Pten positively regulates brown adipose function, energy expenditure, and longevity", "volume": "15", "author": "Ortega-Molina", "year": "2012", "journal-title": "Cell Metab."}, {"key": "2019102518152900300_B78", "doi-asserted-by": "publisher", "first-page": "652", "DOI": "10.1038/nrurol.2012.185", "article-title": "The complexity of prostate cancer: genomic alterations and heterogeneity", "volume": "9", "author": "Boyd", "year": "2012", "journal-title": "Nat. Rev. Urol."}, {"key": "2019102518152900300_B79", "doi-asserted-by": "publisher", "first-page": "1011", "DOI": "10.1016/j.cell.2015.10.025", "article-title": "The molecular taxonomy of primary prostate cancer", "volume": "163", "author": "Cancer Genome Atlas Research Network", "year": "2015", "journal-title": "Cell"}, {"key": "2019102518152900300_B80", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1016/S1535-6108(03)00215-0", "article-title": "Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer", "volume": "4", "author": "Wang", "year": "2003", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B81", "doi-asserted-by": "publisher", "first-page": "666", "DOI": "10.1016/j.cell.2013.03.021", "article-title": "Punctuated evolution of prostate cancer genomes", "volume": "153", "author": "Baca", "year": "2013", "journal-title": "Cell"}, {"key": "2019102518152900300_B82", "doi-asserted-by": "publisher", "first-page": "6563", "DOI": "10.1158/1078-0432.CCR-11-1244", "article-title": "PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients", "volume": "17", "author": "Lotan", "year": "2011", "journal-title": "Clin. Cancer Res."}, {"key": "2019102518152900300_B83", "first-page": "95", "article-title": "Role of PTEN gene in progression of prostate cancer", "volume": "4", "author": "Pourmand", "year": "2007", "journal-title": "Urol. J."}, {"key": "2019102518152900300_B84", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1186/gm237", "article-title": "Genome interrupted: sequencing of prostate cancer reveals the importance of chromosomal rearrangements", "volume": "3", "author": "Kumar", "year": "2011", "journal-title": "Genome Med."}, {"key": "2019102518152900300_B85", "doi-asserted-by": "publisher", "first-page": "187", "DOI": "10.1111/j.1365-2559.2011.04041.x", "article-title": "Molecular genetics of prostate cancer: emerging appreciation of genetic complexity", "volume": "60", "author": "Barbieri", "year": "2012", "journal-title": "Histopathology"}, {"key": "2019102518152900300_B86", "doi-asserted-by": "publisher", "first-page": "579", "DOI": "10.1002/gcc.21944", "article-title": "High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer", "volume": "51", "author": "Boyd", "year": "2012", "journal-title": "Genes Chromosomes Cancer"}, {"key": "2019102518152900300_B87", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1016/j.tips.2010.12.005", "article-title": "Non-genomic loss of PTEN function in cancer: not in my genes", "volume": "32", "author": "Leslie", "year": "2011", "journal-title": "Trends Pharmacol. Sci."}, {"key": "2019102518152900300_B88", "doi-asserted-by": "publisher", "first-page": "678", "DOI": "10.1038/sj.bjc.6603924", "article-title": "FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome", "volume": "97", "author": "Yoshimoto", "year": "2007", "journal-title": "Br. J. Cancer"}, {"key": "2019102518152900300_B89", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1016/j.cancergencyto.2006.04.003", "article-title": "Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias", "volume": "169", "author": "Yoshimoto", "year": "2006", "journal-title": "Cancer Genet. Cytogenet."}, {"key": "2019102518152900300_B90", "doi-asserted-by": "publisher", "first-page": "505", "DOI": "10.1002/path.2559", "article-title": "PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer", "volume": "218", "author": "Sircar", "year": "2009", "journal-title": "J. Pathol."}, {"key": "2019102518152900300_B91", "doi-asserted-by": "publisher", "first-page": "1206", "DOI": "10.1002/pros.23003", "article-title": "A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer", "volume": "75", "author": "Troyer", "year": "2015", "journal-title": "Prostate"}, {"key": "2019102518152900300_B92", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1002/gcc.20939", "article-title": "PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications", "volume": "51", "author": "Yoshimoto", "year": "2012", "journal-title": "Genes Chromosomes Cancer"}, {"key": "2019102518152900300_B93", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1186/1471-2407-12-543", "article-title": "PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity", "volume": "12", "author": "Choucair", "year": "2012", "journal-title": "BMC Cancer"}, {"key": "2019102518152900300_B94", "first-page": "5430", "article-title": "PTEN genomic deletion defines favorable prognostic biomarkers in localized prostate cancer: a systematic review and meta-analysis", "volume": "8", "author": "Wang", "year": "2015", "journal-title": "Int. J. Clin. Exp. Med."}, {"key": "2019102518152900300_B95", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1016/j.acthis.2013.04.013", "article-title": "Best practice for PTEN gene and protein assessment in anatomic pathology", "volume": "116", "author": "Carvalho", "year": "2014", "journal-title": "Acta Histochem."}, {"key": "2019102518152900300_B96", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1186/1471-2407-14-128", "article-title": "Can we accurately report PTEN status in advanced colorectal cancer?", "volume": "14", "author": "Hocking", "year": "2014", "journal-title": "BMC Cancer"}, {"key": "2019102518152900300_B97", "doi-asserted-by": "publisher", "first-page": "904", "DOI": "10.1038/modpathol.2016.88", "article-title": "Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH", "volume": "29", "author": "Lotan", "year": "2016", "journal-title": "Mod. Pathol."}, {"key": "2019102518152900300_B98", "doi-asserted-by": "publisher", "first-page": "719", "DOI": "10.1038/modpathol.3800347", "article-title": "Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities", "volume": "18", "author": "Pallares", "year": "2005", "journal-title": "Mod. Pathol."}, {"key": "2019102518152900300_B99", "doi-asserted-by": "publisher", "first-page": "2582", "DOI": "10.1038/bjc.2013.248", "article-title": "Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer", "volume": "108", "author": "Cuzick", "year": "2013", "journal-title": "Br. J. Cancer"}, {"key": "2019102518152900300_B100", "first-page": "1474", "article-title": "Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer", "volume": "9", "author": "Halvorsen", "year": "2003", "journal-title": "Clin. Cancer Res."}, {"key": "2019102518152900300_B101", "doi-asserted-by": "publisher", "first-page": "2333", "DOI": "10.1158/1055-9965.EPI-13-0333-T", "article-title": "Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer", "volume": "22", "author": "Leinonen", "year": "2013", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "2019102518152900300_B102", "doi-asserted-by": "publisher", "first-page": "607", "DOI": "10.1007/s00428-016-1904-2", "article-title": "In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading", "volume": "468", "author": "Picanco-Albuquerque", "year": "2016", "journal-title": "Virchows Archiv"}, {"key": "2019102518152900300_B103", "first-page": "4291", "article-title": "Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage", "volume": "59", "author": "McMenamin", "year": "1999", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B104", "doi-asserted-by": "publisher", "first-page": "698", "DOI": "10.1016/j.humpath.2015.01.008", "article-title": "Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling", "volume": "46", "author": "Shah", "year": "2015", "journal-title": "Hum. Pathol."}, {"key": "2019102518152900300_B105", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1016/j.humpath.2016.04.017", "article-title": "ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma", "volume": "55", "author": "Morais", "year": "2016", "journal-title": "Hum. Pathol."}, {"key": "2019102518152900300_B106", "doi-asserted-by": "publisher", "first-page": "1296", "DOI": "10.1038/sj.bjc.6604680", "article-title": "Is PTEN loss associated with clinical outcome measures in human prostate cancer?", "volume": "99", "author": "McCall", "year": "2008", "journal-title": "Br. J. Cancer"}, {"key": "2019102518152900300_B107", "doi-asserted-by": "publisher", "first-page": "1209", "DOI": "10.1111/iju.12571", "article-title": "PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer", "volume": "21", "author": "Mithal", "year": "2014", "journal-title": "Int. J. Urol."}, {"key": "2019102518152900300_B108", "doi-asserted-by": "crossref", "first-page": "djv346", "DOI": "10.1093/jnci/djv346", "article-title": "A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer", "volume": "108", "author": "Ahearn", "year": "2016", "journal-title": "J. Natl. Cancer Inst."}, {"key": "2019102518152900300_B109", "doi-asserted-by": "publisher", "first-page": "1083", "DOI": "10.1038/modpathol.2009.69", "article-title": "Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression", "volume": "22", "author": "Han", "year": "2009", "journal-title": "Mod. Pathol."}, {"key": "2019102518152900300_B110", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1038/modpathol.2015.136", "article-title": "Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer", "volume": "29", "author": "Murphy", "year": "2016", "journal-title": "Mod. Pathol."}, {"key": "2019102518152900300_B111", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.1016/j.ccr.2011.07.013", "article-title": "Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression", "volume": "20", "author": "Chen", "year": "2011", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B112", "doi-asserted-by": "publisher", "first-page": "902", "DOI": "10.1038/modpathol.2011.207", "article-title": "Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer", "volume": "25", "author": "Reid", "year": "2012", "journal-title": "Mod. Pathol."}, {"key": "2019102518152900300_B113", "doi-asserted-by": "publisher", "first-page": "907", "DOI": "10.1002/pros.22974", "article-title": "SLUG is a direct transcriptional repressor of PTEN tumor suppressor", "volume": "75", "author": "Uygur", "year": "2015", "journal-title": "Prostate"}, {"key": "2019102518152900300_B114", "doi-asserted-by": "publisher", "first-page": "4327", "DOI": "10.1038/onc.2011.144", "article-title": "Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers", "volume": "30", "author": "Wang", "year": "2011", "journal-title": "Oncogene"}, {"key": "2019102518152900300_B115", "doi-asserted-by": "publisher", "first-page": "407", "DOI": "10.1002/ijc.20447", "article-title": "PTEN promoter is methylated in a proportion of invasive breast cancers", "volume": "112", "author": "Khan", "year": "2004", "journal-title": "Int. J. Cancer"}, {"key": "2019102518152900300_B116", "doi-asserted-by": "publisher", "first-page": "1146", "DOI": "10.1093/neuonc/nos140", "article-title": "PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome", "volume": "14", "author": "Mueller", "year": "2012", "journal-title": "Neuro Oncol."}, {"key": "2019102518152900300_B117", "doi-asserted-by": "publisher", "first-page": "e0142373", "DOI": "10.1371/journal.pone.0142373", "article-title": "Dual action of miR-125b as a tumor suppressor and oncomiR-22 promotes prostate cancer tumorigenesis", "volume": "10", "author": "Budd", "year": "2015", "journal-title": "PloS One"}, {"key": "2019102518152900300_B118", "doi-asserted-by": "publisher", "first-page": "10982", "DOI": "10.1038/ncomms10982", "article-title": "Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer", "volume": "7", "author": "Du", "year": "2016", "journal-title": "Nat. Commun."}, {"key": "2019102518152900300_B119", "doi-asserted-by": "publisher", "first-page": "ra29", "DOI": "10.1126/scisignal.2000594", "article-title": "Identification of the miR-106b \u223c25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7\u00a0in transformation", "volume": "3", "author": "Poliseno", "year": "2010", "journal-title": "Sci. Signal."}, {"key": "2019102518152900300_B120", "doi-asserted-by": "publisher", "first-page": "1033", "DOI": "10.1038/nature09144", "article-title": "A coding-independent function of gene and pseudogene mRNAs regulates tumour biology", "volume": "465", "author": "Poliseno", "year": "2010", "journal-title": "Nature"}, {"key": "2019102518152900300_B121", "doi-asserted-by": "publisher", "first-page": "344", "DOI": "10.1016/j.cell.2011.09.029", "article-title": "Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs", "volume": "147", "author": "Tay", "year": "2011", "journal-title": "Cell"}, {"key": "2019102518152900300_B122", "doi-asserted-by": "publisher", "first-page": "353", "DOI": "10.1016/j.cell.2011.07.014", "article-title": "A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?", "volume": "146", "author": "Salmena", "year": "2011", "journal-title": "Cell"}, {"key": "2019102518152900300_B123", "doi-asserted-by": "publisher", "first-page": "7564", "DOI": "10.1073/pnas.0702507104", "article-title": "Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity", "volume": "104", "author": "Saal", "year": "2007", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "2019102518152900300_B124", "doi-asserted-by": "publisher", "first-page": "1717", "DOI": "10.1038/bjc.2015.128", "article-title": "Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone", "volume": "112", "author": "Salvi", "year": "2015", "journal-title": "Br. J. Cancer"}, {"key": "2019102518152900300_B125", "doi-asserted-by": "crossref", "first-page": "35818", "DOI": "10.18632/oncotarget.9027", "article-title": "Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer", "volume": "7", "author": "Xia", "year": "2016", "journal-title": "Oncotarget"}, {"key": "2019102518152900300_B126", "doi-asserted-by": "publisher", "first-page": "11139", "DOI": "10.1073/pnas.1411446111", "article-title": "Copy number alteration burden predicts prostate cancer relapse", "volume": "111", "author": "Hieronymus", "year": "2014", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "2019102518152900300_B127", "doi-asserted-by": "publisher", "first-page": "2405", "DOI": "10.1002/cncr.27954", "article-title": "Genetic markers associated with early cancer-specific mortality following prostatectomy", "volume": "119", "author": "Liu", "year": "2013", "journal-title": "Cancer"}, {"key": "2019102518152900300_B128", "doi-asserted-by": "publisher", "first-page": "202ra122", "DOI": "10.1126/scitranslmed.3006408", "article-title": "A molecular signature predictive of indolent prostate cancer", "volume": "5", "author": "Irshad", "year": "2013", "journal-title": "Sci. Transl. Med."}, {"key": "2019102518152900300_B129", "doi-asserted-by": "publisher", "first-page": "R83", "DOI": "10.1530/ERC-12-0394", "article-title": "Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer", "volume": "20", "author": "Bitting", "year": "2013", "journal-title": "Endocr.-Relat. Cancer"}, {"key": "2019102518152900300_B130", "author": "Wu", "first-page": "263", "year": "2016", "article-title": "The PI3K-mTOR pathway in prostate cancer: biological significance and therapeutic opportunities", "volume-title": "PI3K-mTOR in Cancer and Cancer Therapy", "DOI": "10.1007/978-3-319-34211-5", "doi-asserted-by": "publisher"}, {"key": "2019102518152900300_B131", "doi-asserted-by": "publisher", "first-page": "150", "DOI": "10.1016/j.eururo.2013.03.040", "article-title": "Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)", "volume": "64", "author": "Templeton", "year": "2013", "journal-title": "Eur. Urol."}, {"key": "2019102518152900300_B132", "doi-asserted-by": "publisher", "first-page": "1697", "DOI": "10.1056/NEJMoa1506859", "article-title": "DNA-repair defects and olaparib in metastatic prostate cancer", "volume": "373", "author": "Mateo", "year": "2015", "journal-title": "N. Engl. J. Med."}, {"key": "2019102518152900300_B133", "doi-asserted-by": "publisher", "first-page": "1177", "DOI": "10.1016/j.eururo.2014.08.053", "article-title": "High efficacy of combination therapy using PI3K/AKT inhibitors with androgen deprivation in prostate cancer preclinical models", "volume": "67", "author": "Marques", "year": "2015", "journal-title": "Eur. Urol."}, {"key": "2019102518152900300_B134", "doi-asserted-by": "crossref", "first-page": "1793", "DOI": "10.3892/ijo.2014.2601", "article-title": "Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities (review)", "volume": "45", "author": "Toren", "year": "2014", "journal-title": "Int. J. Oncol."}, {"key": "2019102518152900300_B135", "doi-asserted-by": "publisher", "first-page": "1261", "DOI": "10.1126/science.1173569", "article-title": "Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a", "volume": "325", "author": "Fine", "year": "2009", "journal-title": "Science"}, {"key": "2019102518152900300_B136", "doi-asserted-by": "publisher", "first-page": "318", "DOI": "10.1186/1471-2407-9-318", "article-title": "Par-3 partitioning defective 3 homolog (C. elegans) and androgen-induced prostate proliferative shutoff associated protein genes are mutationally inactivated in prostate cancer cells", "volume": "9", "author": "Kunnev", "year": "2009", "journal-title": "BMC Cancer"}, {"key": "2019102518152900300_B137", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1016/S1535-6108(03)00021-7", "article-title": "PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms", "volume": "3", "author": "Freeman", "year": "2003", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B138", "doi-asserted-by": "publisher", "first-page": "40057", "DOI": "10.1074/jbc.M303621200", "article-title": "Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades", "volume": "278", "author": "Lu", "year": "2003", "journal-title": "J. Biol. Chem."}, {"key": "2019102518152900300_B139", "doi-asserted-by": "publisher", "first-page": "4901", "DOI": "10.1242/jcs.02594", "article-title": "TGFbeta-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN", "volume": "118", "author": "Vogelmann", "year": "2005", "journal-title": "J. Cell Sci."}, {"key": "2019102518152900300_B140", "doi-asserted-by": "publisher", "first-page": "572", "DOI": "10.1158/0008-5472.CAN-10-2314", "article-title": "Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer", "volume": "71", "author": "Hodgson", "year": "2011", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B141", "doi-asserted-by": "publisher", "first-page": "2759", "DOI": "10.1074/jbc.M114.607846", "article-title": "Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells", "volume": "290", "author": "Lee", "year": "2015", "journal-title": "J. Biol. Chem."}, {"key": "2019102518152900300_B142", "doi-asserted-by": "publisher", "first-page": "792", "DOI": "10.1016/j.ccr.2011.05.006", "article-title": "Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth", "volume": "19", "author": "Mulholland", "year": "2011", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B143", "doi-asserted-by": "publisher", "first-page": "1612", "DOI": "10.1038/modpathol.2014.70", "article-title": "Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer", "volume": "27", "author": "Krohn", "year": "2014", "journal-title": "Mod. Pathol."}, {"key": "2019102518152900300_B144", "doi-asserted-by": "publisher", "first-page": "699", "DOI": "10.1002/path.1929", "article-title": "The PTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletion", "volume": "208", "author": "Verhagen", "year": "2006", "journal-title": "J. Pathol."}, {"key": "2019102518152900300_B145", "doi-asserted-by": "publisher", "first-page": "678", "DOI": "10.1038/sj.bjc.6605554", "article-title": "Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer", "volume": "102", "author": "Reid", "year": "2010", "journal-title": "Br. J. Cancer"}, {"key": "2019102518152900300_B146", "doi-asserted-by": "publisher", "first-page": "645", "DOI": "10.1111/j.1365-2559.2011.04116.x", "article-title": "Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer", "volume": "60", "author": "Bismar", "year": "2012", "journal-title": "Histopathology"}, {"key": "2019102518152900300_B147", "doi-asserted-by": "publisher", "first-page": "401", "DOI": "10.1016/j.ajpath.2012.04.026", "article-title": "Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer", "volume": "181", "author": "Krohn", "year": "2012", "journal-title": "Am. J. Pathol."}, {"key": "2019102518152900300_B148", "doi-asserted-by": "crossref", "first-page": "24146", "DOI": "10.1038/srep24146", "article-title": "Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity", "volume": "6", "author": "Zhong", "year": "2016", "journal-title": "Sci. Rep."}, {"key": "2019102518152900300_B149", "doi-asserted-by": "publisher", "first-page": "159", "DOI": "10.1016/j.ccr.2013.01.002", "article-title": "Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer", "volume": "23", "author": "Weischenfeldt", "year": "2013", "journal-title": "Cancer Cell"}, {"key": "2019102518152900300_B150", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1038/modpathol.2012.162", "article-title": "PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade", "volume": "26", "author": "Yoshimoto", "year": "2013", "journal-title": "Mod. Pathol."}, {"key": "2019102518152900300_B151", "doi-asserted-by": "publisher", "first-page": "559", "DOI": "10.1002/path.1545", "article-title": "Expression of PTEN in malignant and non-malignant human prostate tissues: comparison with p27 protein expression", "volume": "203", "author": "Fenic", "year": "2004", "journal-title": "J. Pathol."}, {"key": "2019102518152900300_B152", "doi-asserted-by": "publisher", "first-page": "895", "DOI": "10.1002/pros.20411", "article-title": "Loss of PTEN is associated with progression to androgen independence", "volume": "66", "author": "Bertram", "year": "2006", "journal-title": "Prostate"}, {"key": "2019102518152900300_B153", "doi-asserted-by": "publisher", "first-page": "3860", "DOI": "10.1158/1078-0432.CCR-07-0091", "article-title": "Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation", "volume": "13", "author": "Bedolla", "year": "2007", "journal-title": "Clin. Cancer Res."}, {"key": "2019102518152900300_B154", "doi-asserted-by": "publisher", "first-page": "1543", "DOI": "10.1038/modpathol.2012.104", "article-title": "Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer", "volume": "25", "author": "Chaux", "year": "2012", "journal-title": "Mod. Pathol."}, {"key": "2019102518152900300_B155", "doi-asserted-by": "publisher", "first-page": "509", "DOI": "10.1007/s00428-004-1004-6", "article-title": "Reduction of PTEN and p27kip1 expression correlates with tumor grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies", "volume": "444", "author": "Dreher", "year": "2004", "journal-title": "Virchows Archiv"}, {"key": "2019102518152900300_B156", "doi-asserted-by": "publisher", "first-page": "6063", "DOI": "10.1002/cncr.27689", "article-title": "An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy", "volume": "118", "author": "Antonarakis", "year": "2012", "journal-title": "Cancer"}, {"key": "2019102518152900300_B157", "first-page": "304", "article-title": "Mutations of PTEN/MMAC1\u00a0in primary prostate cancers from Chinese patients", "volume": "7", "author": "Dong", "year": "2001", "journal-title": "Clin. Cancer Res."}, {"key": "2019102518152900300_B158", "doi-asserted-by": "publisher", "first-page": "1284", "DOI": "10.1002/ijc.22359", "article-title": "Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis", "volume": "120", "author": "Schmitz", "year": "2007", "journal-title": "Int. J. Cancer"}, {"key": "2019102518152900300_B159", "doi-asserted-by": "publisher", "first-page": "298", "DOI": "10.1038/nm.4045", "article-title": "Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer", "volume": "22", "author": "Beltran", "year": "2016", "journal-title": "Nat. Med."}, {"key": "2019102518152900300_B160", "first-page": "811", "article-title": "Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas", "volume": "4", "author": "Wang", "year": "1998", "journal-title": "Clin. Cancer Res."}, {"key": "2019102518152900300_B161", "first-page": "204", "article-title": "Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues", "volume": "58", "author": "Suzuki", "year": "1998", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B162", "doi-asserted-by": "publisher", "first-page": "1979", "DOI": "10.1038/sj.onc.1202119", "article-title": "PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate", "volume": "17", "author": "Dong", "year": "1998", "journal-title": "Oncogene"}, {"key": "2019102518152900300_B163", "doi-asserted-by": "publisher", "first-page": "685", "DOI": "10.1038/ng.2279", "article-title": "Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer", "volume": "44", "author": "Barbieri", "year": "2012", "journal-title": "Nat. Genet."}, {"key": "2019102518152900300_B164", "doi-asserted-by": "publisher", "first-page": "8504", "DOI": "10.1158/0008-5472.CAN-07-0673", "article-title": "Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis", "volume": "67", "author": "Lapointe", "year": "2007", "journal-title": "Cancer Res."}, {"key": "2019102518152900300_B165", "doi-asserted-by": "publisher", "first-page": "S32", "DOI": "10.1038/sj.pcan.4500457", "article-title": "PTEN/MMAC1 mutations in prostate cancer", "volume": "3", "author": "Muller", "year": "2000", "journal-title": "Prostate Cancer Prostatic Dis."}, {"key": "2019102518152900300_B166", "doi-asserted-by": "publisher", "first-page": "D805", "DOI": "10.1093/nar/gku1075", "article-title": "COSMIC: exploring the world's knowledge of somatic mutations in human cancer", "volume": "43", "author": "Forbes", "year": "2015", "journal-title": "Nucleic Acids Res."}], "container-title": ["Clinical Science"], "language": "en", "link": [{"URL": "http://portlandpress.com/clinsci/article-pdf/131/3/197/445108/cs1310197.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://portlandpress.com/clinsci/article-pdf/131/3/197/445108/cs1310197.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 26]], "date-time": "2019-10-26T01:37:33Z", "timestamp": 1572053853000}, "score": 21.183874, "issued": {"date-parts": [[2017, 1, 5]]}, "references-count": 166, "journal-issue": {"published-print": {"date-parts": [[2017, 2, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1042/cs20160026", "relation": {"cites": []}, "ISSN": ["0143-5221", "1470-8736"], "issn-type": [{"value": "0143-5221", "type": "print"}, {"value": "1470-8736", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T06:37:12Z", "timestamp": 1575441432409}, "reference-count": 0, "publisher": "Ferrata Storti Foundation (Haematologica)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Haematologica"], "published-print": {"date-parts": [[2014, 6, 1]]}, "DOI": "10.3324/haematol.2013.096438", "type": "journal-article", "created": {"date-parts": [[2014, 2, 22]], "date-time": "2014-02-22T05:23:56Z", "timestamp": 1393046636000}, "page": "1062-1068", "source": "Crossref", "is-referenced-by-count": 38, "title": ["Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels"], "prefix": "10.3324", "volume": "99", "author": [{"given": "A. M.", "family": "Gomes", "sequence": "first", "affiliation": []}, {"given": "M. V. D.", "family": "Soares", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Ribeiro", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Caldas", "sequence": "additional", "affiliation": []}, {"given": "V.", "family": "Povoa", "sequence": "additional", "affiliation": []}, {"given": "L. R.", "family": "Martins", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Melao", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Serra-Caetano", "sequence": "additional", "affiliation": []}, {"given": "A. B.", "family": "de Sousa", "sequence": "additional", "affiliation": []}, {"given": "J. F.", "family": "Lacerda", "sequence": "additional", "affiliation": []}, {"given": "J. T.", "family": "Barata", "sequence": "additional", "affiliation": []}], "member": "1856", "published-online": {"date-parts": [[2014, 2, 21]]}, "container-title": ["Haematologica"], "language": "en", "deposited": {"date-parts": [[2014, 7, 18]], "date-time": "2014-07-18T13:18:58Z", "timestamp": 1405689538000}, "score": 20.350925, "issued": {"date-parts": [[2014, 2, 21]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 5, 31]]}, "published-print": {"date-parts": [[2014, 6, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.3324/haematol.2013.096438", "ISSN": ["0390-6078", "1592-8721"], "issn-type": [{"value": "0390-6078", "type": "print"}, {"value": "1592-8721", "type": "electronic"}], "subject": ["Hematology"]}, {"institution": {"name": "bioRxiv", "place": ["-"], "acronym": ["-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:47:56Z", "timestamp": 1574887676954}, "posted": {"date-parts": [[2018, 10, 13]]}, "group-title": "Bioinformatics", "reference-count": 10, "publisher": "Cold Spring Harbor Laboratory", "content-domain": {"domain": [], "crossmark-restriction": false}, "accepted": {"date-parts": [[2018, 10, 13]]}, "abstract": "<jats:title>Abstract</jats:title><jats:p>Cell-cell communication via pathway cross-talks within a single species have been studied <jats:italic>in silico</jats:italic> recently to decipher various disease phenotype. However, computational prediction of pathway cross-talks among multiple species in a data-driven manner is yet to be explored. In this article, I present XTalkiiS (Cross-talks between inter-/intra species pathways), a tool to automatically predict pathway cross-talks from data-driven models of pathway network, both within the same organism (intra-species) and between two organisms (inter-species). XTalkiiS starts with retrieving and listing up-to-date pathway information in all the species available in KEGG database using RESTful APIs (exploiting KEGG web services) and an in-house built web crawler. I hypothesize that data-driven network models can be built by simultaneously quantifying co-expression of pathway components (i.e. genes/proteins) in matched samples in multiple organisms. Next, XTalkiiS loads a data-driven pathway network and applies a novel cross-talk modelling approach to determine interactions among known KEGG pathways in selected organisms. The potentials of XTalkiiS are huge as it paves the way of finding novel insights into mechanisms how pathways from two species (ideally host-parasite) may interact that may contribute to the various phenotype of interests such as malaria disease. XTalkiiS is made open sourced at <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" xlink:href=\"https://github.com/Akmazad/XTalkiiS\">https://github.com/Akmazad/XTalkiiS</jats:ext-link> and its binary files are freely available for downloading from <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" xlink:href=\"https://sourceforge.net/projects/xtalkiis/\">https://sourceforge.net/projects/xtalkiis/</jats:ext-link>.</jats:p>", "DOI": "10.1101/437541", "type": "posted-content", "created": {"date-parts": [[2018, 10, 13]], "date-time": "2018-10-13T14:04:22Z", "timestamp": 1539439462000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["XTalkiiS: a tool for finding data-driven cross-talks between intra-/inter-species pathways"], "prefix": "10.1101", "author": [{"given": "A. K. M.", "family": "Azad", "sequence": "first", "affiliation": []}], "member": "246", "reference": [{"key": "2019072208423633000_437541v1.1", "DOI": "10.1038/75556", "doi-asserted-by": "publisher"}, {"key": "2019072208423633000_437541v1.2", "unstructured": "A. Azad , A. Lawen , and J. M. Keith . Cross-talk categorisations in data-driven models of signalling networks: A system-level view. In F. Uchiumi , editor, Gene Expression and Regulation in Mammalian Cells, chapter 5. IntechOpen, Rijeka, 2018.", "DOI": "10.5772/intechopen.72408", "doi-asserted-by": "crossref"}, {"key": "2019072208423633000_437541v1.3", "DOI": "10.1371/journal.pone.0173331", "doi-asserted-by": "publisher"}, {"key": "2019072208423633000_437541v1.4", "unstructured": "A. K. M. Azad . Kpgminer: A tool for retrieving pathway genes from kegg pathway database. bioRxiv, 2018.", "DOI": "10.1101/416131", "doi-asserted-by": "crossref"}, {"key": "2019072208423633000_437541v1.5", "volume": "9", "first-page": "2", "year": "2015", "article-title": "Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling", "journal-title": "BMC Syst Biol", "DOI": "10.1186/s12918-014-0135-x", "doi-asserted-by": "crossref"}, {"issue": "8", "key": "2019072208423633000_437541v1.6", "doi-asserted-by": "crossref", "first-page": "e70498", "DOI": "10.1371/journal.pone.0070498", "article-title": "Voting-based cancer module identification by combining topological and data-driven properties", "volume": "8", "year": "2013", "journal-title": "PLoS ONE"}, {"key": "2019072208423633000_437541v1.7", "DOI": "10.1093/nar/gkt1102", "doi-asserted-by": "publisher"}, {"key": "2019072208423633000_437541v1.8", "DOI": "10.1093/nar/gkr1074", "doi-asserted-by": "publisher"}, {"key": "2019072208423633000_437541v1.9", "DOI": "10.1038/msb.2012.25", "doi-asserted-by": "publisher"}, {"issue": "4", "key": "2019072208423633000_437541v1.10", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1111/1758-2229.12553", "article-title": "Interspecies cross-talk between co-cultured Pseudomonas putida and Escherichia coli", "volume": "9", "year": "2017", "journal-title": "Environ Microbiol Rep"}], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1101/437541", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 22]], "date-time": "2019-07-22T15:45:22Z", "timestamp": 1563810322000}, "score": 20.17433, "issued": {"date-parts": [[2018, 10, 13]]}, "references-count": 10, "URL": "http://dx.doi.org/10.1101/437541", "relation": {"cites": []}, "subtype": "preprint"}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T17:43:37Z", "timestamp": 1576777417844}, "reference-count": 39, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 1, 1]], "date-time": "2013-01-01T00:00:00Z", "timestamp": 1356998400000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100008730", "name": "Norwegian Cancer Society", "doi-asserted-by": "crossref", "award": ["PR-2006-0442"]}, {"DOI": "10.13039/501100005416", "name": "Research Council of Norway", "doi-asserted-by": "crossref", "award": []}, {"name": "Health Region South East", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cellular Signalling"], "published-print": {"date-parts": [[2013, 1]]}, "DOI": "10.1016/j.cellsig.2012.08.012", "type": "journal-article", "created": {"date-parts": [[2012, 9, 5]], "date-time": "2012-09-05T06:46:20Z", "timestamp": 1346827580000}, "page": "12-18", "source": "Crossref", "is-referenced-by-count": 31, "title": ["NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway"], "prefix": "10.1016", "volume": "25", "author": [{"given": "Peter W.", "family": "Eide", "sequence": "first", "affiliation": []}, {"given": "Lina", "family": "Cekaite", "sequence": "additional", "affiliation": []}, {"given": "Stine A.", "family": "Danielsen", "sequence": "additional", "affiliation": []}, {"given": "Ina A.", "family": "Eilertsen", "sequence": "additional", "affiliation": []}, {"given": "Ane", "family": "Kjenseth", "sequence": "additional", "affiliation": []}, {"given": "Tone A.", "family": "Fykerud", "sequence": "additional", "affiliation": []}, {"given": "Trude H.", "family": "\u00c5gesen", "sequence": "additional", "affiliation": []}, {"given": "Jarle", "family": "Bruun", "sequence": "additional", "affiliation": []}, {"given": "Edgar", "family": "Rivedal", "sequence": "additional", "affiliation": []}, {"given": "Ragnhild A.", "family": "Lothe", "sequence": "additional", "affiliation": []}, {"given": "Edward", "family": "Leithe", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cellular Signalling"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0898656812002410?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0898656812002410?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 3]], "date-time": "2019-07-03T11:40:32Z", "timestamp": 1562154032000}, "score": 20.133984, "issued": {"date-parts": [[2013, 1]]}, "references-count": 39, "journal-issue": {"published-print": {"date-parts": [[2013, 1]]}, "issue": "1"}, "alternative-id": ["S0898656812002410"], "URL": "http://dx.doi.org/10.1016/j.cellsig.2012.08.012", "ISSN": ["0898-6568"], "issn-type": [{"value": "0898-6568", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T13:14:45Z", "timestamp": 1574774085283}, "reference-count": 51, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 6, 1]], "date-time": "2016-06-01T00:00:00Z", "timestamp": 1464739200000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "Paolo Nuciforo and Jose Jimenez for excellent technical assistance with FFPE and immunohistochemistry", "award": []}, {"name": "Marta Vilaro for statistical support and Francisco S\u00e1nchez V\u00e9lez for graphic design", "award": []}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "lungcancerjournal.info", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Lung Cancer"], "published-print": {"date-parts": [[2016, 6]]}, "DOI": "10.1016/j.lungcan.2016.03.001", "type": "journal-article", "created": {"date-parts": [[2016, 3, 10]], "date-time": "2016-03-10T03:33:12Z", "timestamp": 1457580792000}, "page": "1-6", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)"], "prefix": "10.1016", "volume": "96", "author": [{"given": "S.", "family": "Cedr\u00e9s", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Ponce-Aix", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Pardo-Aranda", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Navarro-Mendivil", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Martinez-Marti", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Zugazagoitia", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Sansano", "sequence": "additional", "affiliation": []}, {"given": "M.A.", "family": "Montoro", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Enguita", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Felip", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Lung Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0169500216302379?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0169500216302379?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 5]], "date-time": "2019-09-05T11:16:00Z", "timestamp": 1567682160000}, "score": 19.798613, "issued": {"date-parts": [[2016, 6]]}, "references-count": 51, "alternative-id": ["S0169500216302379"], "URL": "http://dx.doi.org/10.1016/j.lungcan.2016.03.001", "ISSN": ["0169-5002"], "issn-type": [{"value": "0169-5002", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)", "name": "articletitle", "label": "Article Title"}, {"value": "Lung Cancer", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.lungcan.2016.03.001", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T10:23:25Z", "timestamp": 1576837405696}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Cancer Therapeutics"], "published-print": {"date-parts": [[2011, 6, 1]]}, "DOI": "10.1158/1535-7163.mct-10-1089", "type": "journal-article", "created": {"date-parts": [[2011, 4, 14]], "date-time": "2011-04-14T02:58:22Z", "timestamp": 1302749902000}, "page": "1093-1101", "source": "Crossref", "is-referenced-by-count": 127, "title": ["PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer"], "prefix": "10.1158", "volume": "10", "author": [{"given": "A. M.", "family": "Gonzalez-Angulo", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Ferrer-Lozano", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Stemke-Hale", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Sahin", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "J. A.", "family": "Barrera", "sequence": "additional", "affiliation": []}, {"given": "O.", "family": "Burgues", "sequence": "additional", "affiliation": []}, {"given": "A. M.", "family": "Lluch", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "G. N.", "family": "Hortobagyi", "sequence": "additional", "affiliation": []}, {"given": "G. B.", "family": "Mills", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Meric-Bernstam", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2011, 4, 13]]}, "container-title": ["Molecular Cancer Therapeutics"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1535-7163.MCT-10-1089", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 22]], "date-time": "2016-12-22T23:43:20Z", "timestamp": 1482450200000}, "score": 19.739876, "issued": {"date-parts": [[2011, 4, 13]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2011, 6, 8]]}, "published-print": {"date-parts": [[2011, 6, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1158/1535-7163.mct-10-1089", "ISSN": ["1535-7163", "1538-8514"], "issn-type": [{"value": "1535-7163", "type": "print"}, {"value": "1538-8514", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T23:06:57Z", "timestamp": 1574464017391}, "reference-count": 50, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 7, 1]], "date-time": "2012-07-01T00:00:00Z", "timestamp": 1341100800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Lung Cancer"], "published-print": {"date-parts": [[2012, 7]]}, "DOI": "10.1016/j.lungcan.2012.02.022", "type": "journal-article", "created": {"date-parts": [[2012, 3, 27]], "date-time": "2012-03-27T16:00:52Z", "timestamp": 1332864052000}, "page": "192-198", "source": "Crossref", "is-referenced-by-count": 37, "title": ["Exploratory analysis of activation of PTEN\u2013PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)"], "prefix": "10.1016", "volume": "77", "author": [{"given": "S.", "family": "Cedr\u00e9s", "sequence": "first", "affiliation": []}, {"given": "M.A.", "family": "Montero", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Martinez", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Martinez", "sequence": "additional", "affiliation": []}, {"given": "V.", "family": "Rodr\u00edguez-Freixin\u00f3s", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Torrejon", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Gabaldon", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Salcedo", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Ramon y Cajal", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Felip", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Lung Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0169500212001110?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0169500212001110?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 24]], "date-time": "2018-11-24T22:25:50Z", "timestamp": 1543098350000}, "score": 19.342266, "issued": {"date-parts": [[2012, 7]]}, "references-count": 50, "journal-issue": {"published-print": {"date-parts": [[2012, 7]]}, "issue": "1"}, "alternative-id": ["S0169500212001110"], "URL": "http://dx.doi.org/10.1016/j.lungcan.2012.02.022", "ISSN": ["0169-5002"], "issn-type": [{"value": "0169-5002", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T19:06:24Z", "timestamp": 1575313584925}, "reference-count": 65, "publisher": "American Society for Clinical Investigation", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Clin. Invest."], "published-print": {"date-parts": [[2008, 11, 3]]}, "DOI": "10.1172/jci34616", "type": "journal-article", "created": {"date-parts": [[2008, 10, 15]], "date-time": "2008-10-15T17:25:57Z", "timestamp": 1224091557000}, "page": "3762-3774", "source": "Crossref", "is-referenced-by-count": 234, "title": ["PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability"], "prefix": "10.1172", "volume": "118", "author": [{"given": "Ana", "family": "Silva", "sequence": "first", "affiliation": []}, {"given": "J. Andr\u00e9s", "family": "Yunes", "sequence": "additional", "affiliation": []}, {"given": "Bruno A.", "family": "Cardoso", "sequence": "additional", "affiliation": []}, {"given": "Leila R.", "family": "Martins", "sequence": "additional", "affiliation": []}, {"given": "Patr\u00edcia Y.", "family": "Jotta", "sequence": "additional", "affiliation": []}, {"given": "Miguel", "family": "Abecasis", "sequence": "additional", "affiliation": []}, {"given": "Alexandre E.", "family": "Nowill", "sequence": "additional", "affiliation": []}, {"given": "Nick R.", "family": "Leslie", "sequence": "additional", "affiliation": []}, {"given": "Angelo A.", "family": "Cardoso", "sequence": "additional", "affiliation": []}, {"given": "Joao T.", "family": "Barata", "sequence": "additional", "affiliation": []}], "member": "232", "reference": [{"key": "B1", "DOI": "10.1038/nrc839", "doi-asserted-by": "publisher"}, {"key": "B2", "DOI": "10.1016/S1535-6108(03)00248-4", "doi-asserted-by": "publisher"}, {"key": "B3", "DOI": "10.1084/jem.20040789", "doi-asserted-by": "publisher"}, {"key": "B4", "DOI": "10.1182/blood-2002-11-3429", "doi-asserted-by": "publisher"}, {"key": "B5", "DOI": "10.1182/blood.V98.9.2853", "doi-asserted-by": "publisher"}, {"key": "B6", "DOI": "10.1182/blood-2005-08-3076", "doi-asserted-by": "publisher"}, {"key": "B7", "DOI": "10.1093/jnci/91.22.1922", "doi-asserted-by": "publisher"}, {"key": "B8", "DOI": "10.1200/JCO.2004.02.141", "doi-asserted-by": "publisher"}, {"key": "B9", "DOI": "10.1038/1235", "doi-asserted-by": "publisher"}, {"key": "B10", "DOI": "10.1073/pnas.96.4.1563", "doi-asserted-by": "publisher"}, {"key": "B11", "DOI": "10.1016/S1074-7613(01)00134-0", "doi-asserted-by": "publisher"}, {"key": "B12", "DOI": "10.1038/nature04703", "doi-asserted-by": "publisher"}, {"key": "B13", "DOI": "10.1038/nature04747", "doi-asserted-by": "publisher"}, {"key": "B14", "author": "Sakai", "volume": "92", "first-page": "3410", "year": "1998", "journal-title": "Blood."}, {"key": "B15", "DOI": "10.1128/MCB.20.18.6945-6957.2000", "doi-asserted-by": "publisher"}, {"key": "B16", "author": "Xu", "volume": "13", "first-page": "285", "year": "2002", "journal-title": "Cell Growth Differ."}, {"key": "B17", "DOI": "10.1038/nrc1819", "doi-asserted-by": "publisher"}, {"key": "B18", "DOI": "10.1074/jbc.M111899200", "doi-asserted-by": "publisher"}, {"key": "B19", "DOI": "10.1093/emboj/cdg513", "doi-asserted-by": "publisher"}, {"key": "B20", "DOI": "10.1128/MCB.20.14.5010-5018.2000", "doi-asserted-by": "publisher"}, {"key": "B21", "DOI": "10.1074/jbc.M009134200", "doi-asserted-by": "publisher"}, {"key": "B22", "DOI": "10.1016/S0014-5793(02)03274-X", "doi-asserted-by": "publisher"}, {"key": "B23", "author": "Tolkacheva", "volume": "61", "first-page": "4985", "year": "2001", "journal-title": "Cancer Res."}, {"key": "B24", "author": "Daya-Makin", "volume": "54", "first-page": "2262", "year": "1994", "journal-title": "Cancer Res."}, {"key": "B25", "DOI": "10.1038/sj.onc.1204411", "doi-asserted-by": "publisher"}, {"key": "B26", "DOI": "10.1016/j.cell.2006.05.041", "doi-asserted-by": "publisher"}, {"key": "B27", "DOI": "10.1182/blood-2005-11-013672", "doi-asserted-by": "publisher"}, {"key": "B28", "DOI": "10.1126/science.7846532", "doi-asserted-by": "publisher"}, {"key": "B29", "author": "Szatrowski", "volume": "51", "first-page": "794", "year": "1991", "journal-title": "Cancer Res."}, {"key": "B30", "DOI": "10.1126/science.275.5306.1649", "doi-asserted-by": "publisher"}, {"key": "B31", "DOI": "10.1038/43459", "doi-asserted-by": "publisher"}, {"key": "B32", "DOI": "10.1074/jbc.M410690200", "doi-asserted-by": "publisher"}, {"key": "B33", "DOI": "10.1038/nature05886", "doi-asserted-by": "publisher"}, {"key": "B34", "DOI": "10.1016/S1535-6108(02)00018-1", "doi-asserted-by": "publisher"}, {"key": "B35", "DOI": "10.1038/sj.leu.2404302", "doi-asserted-by": "publisher"}, {"key": "B36", "author": "Hare", "volume": "165", "first-page": "2410", "year": "2000", "journal-title": "J. Immunol.", "DOI": "10.4049/jimmunol.165.5.2410", "doi-asserted-by": "crossref"}, {"key": "B37", "DOI": "10.1073/pnas.96.18.10182", "doi-asserted-by": "publisher"}, {"key": "B38", "DOI": "10.1073/pnas.0510570103", "doi-asserted-by": "publisher"}, {"key": "B39", "DOI": "10.1038/nm1636", "doi-asserted-by": "publisher"}, {"key": "B40", "DOI": "10.1200/JCO.2005.01.4944", "doi-asserted-by": "publisher"}, {"key": "B41", "DOI": "10.1182/blood-2002-12-3861", "doi-asserted-by": "publisher"}, {"key": "B42", "DOI": "10.1038/sj.cdd.4401604", "doi-asserted-by": "publisher"}, {"key": "B43", "DOI": "10.1016/j.bbrc.2004.06.038", "doi-asserted-by": "publisher"}, {"key": "B44", "DOI": "10.1097/01.MP.0000067423.83712.74", "doi-asserted-by": "publisher"}, {"key": "B45", "DOI": "10.1038/nature03918", "doi-asserted-by": "publisher"}, {"key": "B46", "DOI": "10.1038/84879", "doi-asserted-by": "publisher"}, {"key": "B47", "DOI": "10.1016/j.cell.2006.11.039", "doi-asserted-by": "publisher"}, {"key": "B48", "DOI": "10.1182/blood-2005-03-0929", "doi-asserted-by": "publisher"}, {"key": "B49", "DOI": "10.1093/hmg/8.2.185", "doi-asserted-by": "publisher"}, {"key": "B50", "DOI": "10.1046/j.1365-2141.2003.04452.x", "doi-asserted-by": "publisher"}, {"key": "B51", "DOI": "10.1016/j.bbrc.2007.02.136", "doi-asserted-by": "publisher"}, {"key": "B52", "author": "He", "volume": "1772", "first-page": "1134", "year": "2007", "journal-title": "Biochim. Biophys. Acta.", "DOI": "10.1016/j.bbadis.2007.07.001", "doi-asserted-by": "crossref"}, {"key": "B53", "DOI": "10.1073/pnas.0407396101", "doi-asserted-by": "publisher"}, {"key": "B54", "DOI": "10.1038/nature01036", "doi-asserted-by": "publisher"}, {"key": "B55", "DOI": "10.1016/j.cell.2007.01.003", "doi-asserted-by": "publisher"}, {"key": "B56", "DOI": "10.1016/j.cell.2006.12.029", "doi-asserted-by": "publisher"}, {"key": "B57", "DOI": "10.1016/j.tibs.2007.05.005", "doi-asserted-by": "publisher"}, {"key": "B58", "DOI": "10.1126/science.1102160", "doi-asserted-by": "publisher"}, {"key": "B59", "DOI": "10.1074/jbc.M309924200", "doi-asserted-by": "publisher"}, {"key": "B60", "DOI": "10.1002/ijc.2910190505", "doi-asserted-by": "publisher"}, {"key": "B61", "author": "Minowada", "volume": "49", "first-page": "891", "year": "1972", "journal-title": "J. Natl. Cancer Inst."}, {"key": "B62", "DOI": "10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J", "doi-asserted-by": "publisher"}, {"key": "B63", "DOI": "10.1002/ijc.2910210207", "doi-asserted-by": "publisher"}, {"key": "B64", "author": "Uckun", "volume": "15", "first-page": "2214", "year": "1997", "journal-title": "J. Clin. Oncol.", "DOI": "10.1200/JCO.1997.15.6.2214", "doi-asserted-by": "crossref"}, {"key": "B65", "author": "Bene", "volume": "9", "first-page": "1783", "year": "1995", "journal-title": "Leukemia."}], "container-title": ["Journal of Clinical Investigation"], "language": "en", "deposited": {"date-parts": [[2019, 5, 14]], "date-time": "2019-05-14T17:51:25Z", "timestamp": 1557856285000}, "score": 19.342266, "issued": {"date-parts": [[2008, 11, 3]]}, "references-count": 65, "journal-issue": {"published-print": {"date-parts": [[2008, 11, 3]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1172/jci34616", "relation": {"cites": []}, "ISSN": ["0021-9738"], "issn-type": [{"value": "0021-9738", "type": "print"}], "subject": ["General Medicine"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}